Xechem - Nicosan genehmigt - Produktionsbeginn - 500 Beiträge pro Seite (Seite 54)

[fjellraeven]

Antwort auf Beitrag Nr.: 34.471.123 von physik am 09.07.08 15:44:29

[steini69]

Antwort auf Beitrag Nr.: 34.471.140 von fjellraeven am 09.07.08 15:46:15

einfach nur krass.

das volumen heute bricht ja alle rekorde bisher.

steini

[fjellraeven]

Antwort auf Beitrag Nr.: 34.471.320 von steini69 am 09.07.08 16:00:54

Kein Wunder bei den Preisen! Da kann jeder Aktienmillionär werden. Was die Aktien dann in einigen Tagen wert sein werden, steht auf einem anderen Blatt.

[OttomanRosen]

NIPRD partners with herbalists for drug production
• Tuesday, Apr 29, 2008
The National Institute for Pharmaceutical Research and Development (NIPRD) is partnering with herbalists in the manufacturing of drugs.

Dr. Yetunde Isii, a Research Fellow in the Institute announced the plan in an interview with our correspondent in Abuja.

Isimi said the institute had already received some prescriptions from the herbalist which were undergoing research to justify their claims.

“WHO is sponsoring the on-going third phase trials of the research?

“We have also started a research on HIV booster and malaria drugs,” Isimi said.

She said that the “NICOSAN” sickle-cell drugs made by the institute was being produced in commercial quantity


http://www.thetidenews.com/article.aspx?qrDate=04/29/2008&qr…

[xtauri]

hi

hat jemand von euch ein paar links zu seiten, auf denen erfahrungsgemäß die anstehenden news bzw. ergebnisse der xechem konferenz von heute zuerst gepostet werden

[Lapalie]

Ist das hier schon bekannt?
http://talesfromabyssinia.blogspot.com/2008/07/greed-destroy…

[EKKI1997]

kann man sich die conference im internet anhören?
gibt es einen link

[EKKI1997]

Antwort auf Beitrag Nr.: 34.479.979 von EKKI1997 am 10.07.08 14:45:38

ok nun habe ich es kapiert.

conference beginnt in 2 stunden und unter dieser nummer:
International: 001 904-596-2360 - Outside the U.S. & Canada
kann man sich registrieren lassen und 1 stunde zuhören.

also bin mal gespannt was passieren wird.


grüsse
ekki

[xtauri]

jetzt gehts los; im IHub sind die jungs schon ganz aufgeregt; einige hören live die konferenz per telefon mit...

[xtauri]

mmhh... die posts die im IHub mitzulesen sind, hören sich nicht gut an... ich glaub das wars...

[gvsj]

Antwort auf Beitrag Nr.: 34.481.661 von xtauri am 10.07.08 17:01:26

was schreiben sie denn????

[xtauri]

Antwort auf Beitrag Nr.: 34.481.704 von gvsj am 10.07.08 17:05:47

sinngemäß das was schon bekannt ist

- Pandey hat xkem ausbluten lassen
- kohle weg
- weitere finanzierung fraglich
- viel bla bla

definitiv keine guten news - der kursverlauf sagt glaub ich alles (kurzes aufbäumen und dann abgekackt...)

[LoloXP]

Antwort auf Beitrag Nr.: 34.481.777 von xtauri am 10.07.08 17:13:45

Ach?, wirklich?

Hätt ich jetzt nicht gedacht!

[Helenium]

Antwort auf Beitrag Nr.: 34.481.777 von xtauri am 10.07.08 17:13:45

hi xtauri,
bist du noch am zuhören?
gibt es was konkreteres?

danke für die info

[fjellraeven]

Antwort auf Beitrag Nr.: 34.482.336 von Helenium am 10.07.08 18:14:58

Man kann der Diskussion im IHUB folgen, was etwas Mühe macht, oder man schaut sich den Kurs an: Die Informationen sind ungefähr dieselben.

Es gibt immer noch Aktionäre, die weiter auf Nicosan setzen, und damit verkennen, dass das Produkt einer Firma relativ unwichtig ist. Entscheidend ist letzlich, wie effektiv das Management ist. Unzählige Unternehmen rund um den Erdball produzieren unzählige Dinge, die niemand braucht oft sogar schädlich sind, die jedoch bestens vermarktet werden. Auch ich habe mich vom Produkt und dessen potenziellen Wert blenden lassen und der Qualität des Managements und dem politisch-sozialen Umfeld zu wenig Beachtung geschenkt.

Immerhin bin ich nun etwas klüger.

[schoeler]

Antwort auf Beitrag Nr.: 34.482.749 von fjellraeven am 10.07.08 19:04:48

Hallo Allerseits,

die Bosse haben mal wieder etwas Ihre Kasse gefüllt. Diese Blenderei ist doch wohl offensichtlich. Aber was soll's 5000 Euronen im Sand.

Gruß sch.

[fjellraeven]

Antwort auf Beitrag Nr.: 34.482.797 von schoeler am 10.07.08 19:12:18

Fisch oder Hai?
Der naive Glaube zahlloser Fische machte sie zum leichten Fang einiger Haie.

[OttomanRosen]

Conference call...........

I think thid is really a cut and dry situation. I took the following away from it today.

1) XKem has a product that works!!!!!!!!!!!!!!!!!!!!!!!!!

2) The are starving for money.

3) Just starting to get the ball rolling in Africa and sales to the three states.

4) They need to end and solve the legaly issues with Pandey as soon as possible.

5) They have the ability in the short term to ramp up production as sales increase.

6) The factories will be finished when more cash comes in.

7) I Agree completely with Swift about the domino effect.

This is a PENNY STOCK they have a 50%-50% chance in my eyes to suceed. BUT when they do those who can wait will be very wealthy.

let the flipper say what they want.Honestly what does it really matter? They have no bearing on this companies quest to survive and get the drug to market.

I'm betting they make it and at this point my million shares and I will hang out and whatch this great story unfold.

good luck all

[OttomanRosen]

Für die hinterbliebene Restliche XeChem Gemeinde ,hier der CC von Dr. Swift, macht euch selbst ein Bild daraus..


CC RECORDING PART 1

http://tinypic.com/player.php?v=2r2natk&s=4

CC RECORDING PART 2 Q/A

http://tinypic.com/player.php?v=f03swk&s=4

CC RECORDING PART 3 Q/A

http://tinypic.com/player.php?v=w7bl92&s=4

[mani40]

wie gewonnen so zeronnen

mit dem Produkt könnte es was werden, jedoch mit 5 MIA genehmigten Aktien bleibt nur die Frage zu welchem Kurs?

[OttomanRosen]

wieso 5 MIA Aktien

es sind lediglich ca. 1,9 MIA Aktien höre doch den CC

[EKKI1997]

was ist da los? +42%

[falconara]

Antwort auf Beitrag Nr.: 34.520.117 von EKKI1997 am 16.07.08 14:25:03

also,
ich sehe -20%

[LoloXP]

Mein Gott, was soll der Gerüchte Kram auf IHUB ?????

[fjellraeven]

25m Nigerians are Sickle Cell Carriers – Minister
08.06.2008


The Minister of Science and Technology, Mrs Grace Ekpiwhre, has said that over four million Nigerians have sickle cell while 25 million others are carriers.

Ekpiwhre, according to a statement, disclosed this in her address at the lecture/sensitisation programme on sickle cell disease in Abuja on Monday.

The minister, who also noted that more than 100,000 children are born with sickle cell disease in Nigeria each year observed that this account for 8 per cent of annual infant mortality.
She explained that sickle cell is a blood disease resulting from a genetic mutation that causes the production of sickle shaped Red Blood Cells (RBCs).

She said that cell therapy could cure sickle cell disease by replacing the sickle cells with healthy new ones.
Nicosan and Ciklavit, she said, were drugs produced by Nigerian companies, namely Xechem Nig. Ltd. and Neimeth Pharmaceuticals plc and are currently used in the management of sickle cell disease in the country.

“They are highly effective drugs that suppress the symptoms associated with sickle cell disease but they are not curative measures” adding that to date, bone marrow transplantation presents the only curative treatment of the disease and thus forms the basis of our excitement today.

In his lecture entitled “Stem Cell Transplantation to cure childhood Diseases” Dr. Alans Wayne recalled the Bone Marrow Transplantation he carried our in 1998 on a Nigerian child, Mr. Chuka Esiobu, who then had sickle cell disease.

He obtained healthy samples from the sibling of the patient with whom he had a 6/6 HLA typing – “perfect Match. Chemotherapy was used to kill off the healthy and sickle blood cells. During this period he was isolated in a completely sterile environment so as to prevent infection due to compromised immune status. Engraftment of the donor blood marrow was then carried out.
Over a period of two months, the donor blood cells gradually took over his blood system. From the period following the transplant till present, his genotype is AA instead of SS. The success of the operation led to the government of the United States sponsoring a second transplant for his younger sibling who consequently went from SS to AS.
The success of the initial transplant was a key factor in his subsequent Promotion to the rank of clinical director of the Paediatric Oncology Branch (POB) and the head of the Hematologic Diseases Section the following year.
This year, 2008 marks the tenth Anniversary of the successful BMT of these two Nigerian children.

http://www.thisdayonline.com/nview.php?id=118911

[falconara]

Antwort auf Beitrag Nr.: 34.659.705 von fjellraeven am 06.08.08 13:34:21

Minister für Wissenschaft und Technologie, Frau Grace Ekpiwhre,
favorisiert sie die Knochenmark-Transplantation ?

[fjellraeven]

Antwort auf Beitrag Nr.: 34.662.899 von falconara am 06.08.08 18:39:47

Nein, sicher nicht! Diese könnte sich auch kaum ein Nigerianer leisten. Aber es ist eben die bislang einzige Methode, mit der man sich von der SCD befreien kann (Heilung). Aber sie betonte auch, dass 2 von nig. Firmen produzierte Medikamente auf dem Markt seien (darunter Nicosan), die äußerst effektiv die Beschwerden bei SCD lindern würden.

[fjellraeven]

[fjellraeven]

Antwort auf Beitrag Nr.: 34.686.875 von fjellraeven am 08.08.08 17:29:23

Volumen über 75 Mio.

[fjellraeven]

Antwort auf Beitrag Nr.: 34.687.007 von fjellraeven am 08.08.08 17:38:07

[Helenium]

hallo miteinander,

ist das jetzt reine zocke oder ist was im busch?

[fjellraeven]

Antwort auf Beitrag Nr.: 34.688.362 von Helenium am 08.08.08 19:16:44

Hallo,
das habe ich mich auch gefragt. Ich vermute, hier wurde gezockt. Gut möglich, dass dies auch noch am Montag der Fall sein wird. Das niedrige Niveau bringt eine große Volatilität mit sich, die zum Zocken reizt.

[OttomanRosen]

Antwort auf Beitrag Nr.: 34.688.607 von fjellraeven am 08.08.08 19:36:08

Wieviele Shares wurden denn, zu 0,0003 verkauft Heute

[fjellraeven]

+ 250% bei fast 200 Mio. Shares - nicht schlecht!
Mein Tipp: Montag gehts noch höher.

Fjell

[fjellraeven]

Antwort auf Beitrag Nr.: 34.690.554 von fjellraeven am 08.08.08 22:21:08

[fvogel]

Antwort auf Beitrag Nr.: 34.688.362 von Helenium am 08.08.08 19:16:44

Hier ist ein ziemlich aktueller Artikel über Xechem.

http://www.thenationonlineng.com/dynamicpage.asp?id=58475

Das ist wahrscheinlich nicht der Grund für den Anstieg und das relativ hohe Volumen, aber dennoch ein kleines Lebenszeichen und Hoffnungsschimmer.

[id4]

Antwort auf Beitrag Nr.: 34.697.506 von fvogel am 11.08.08 10:07:27

na vielleicht wirds ja doch noch was.

ab welchem kurs sind die wieder in deutschland handelbar?

gruss id4

[fvogel]

Antwort auf Beitrag Nr.: 34.698.844 von id4 am 11.08.08 12:43:46

Ich denke das hängt weniger vom Kurs ab.

Entscheidend ist eher in welchem Segment die Aktie in den USA gehandelt wird, ob gewisse Standards eingehalten werden (fristgemä0e Berichte) und dann vielleicht noch, ob sich der Handel in Deutschland lohnt (erwartetes Volumen).

Vielleicht weis das ja noch irgendjemand etwas genauer und verbindlicher?

[Helenium]

Antwort auf Beitrag Nr.: 34.697.506 von fvogel am 11.08.08 10:07:27

hallo fvogel, hallo alle,

fvogel, danke für den bericht. Nicosan wird gelobt und gelobt und das management von xechem wird aufgefordert noch mehr zu tun(auch in andere richtungen)
Die Herstellung des medikaments wirkt sich auch positiv auf die Farmer aus, die die Pflanzen zur Herstellung anbauen.
wie die letzten berichte ja deutlich zeigen sind das schlechte management und die anhängenden rechtsstreite wohl mit der grund für den derzeitigen aktienkurs.
was mich im momemt etwas stutzig macht ist, dass fast 200 mio. Shares gekauft wurden.(mehr als beim letzen anstieg vor ca. 4 wochen)
... nur zocke oder kommt da noch was?....

[mani40]

Antwort auf Beitrag Nr.: 34.699.305 von Helenium am 11.08.08 13:34:24

fand ich auch erstaunlich, aber warum ist aufgrund dieses Umsatze der Kurs nicht wesentlich gestiegen?

[Strandlaeufer1]

Antwort auf Beitrag Nr.: 34.700.341 von mani40 am 11.08.08 15:20:08

nicht wesentlich gestiegen?

250 % an einem Tag !!!
SL1

[fjellraeven]

http://allafrica.com/stories/200808110842.html


Nigeria: Country Intensifies Fight Against Sickle Cell

10. August 2008

[Helenium]

Antwort auf Beitrag Nr.: 34.701.407 von fjellraeven am 11.08.08 17:03:01

vielleicht schaffen die es ja wirklich noch die produktion zu erhöhen, die fabrik endlich fertig zu bauen und entsprechende stückzahlen zu produzieren.
irgendwie scheint da was zu rumoren...
vielleicht erkennt auch nigeria irgendwann, dass gesunde menschen mehr für das land tun können als kranke und zwackt einen teil vom erdölgeld hierfür ab....
und vor allem wäre es allen betroffenen von ganzem herzen gegönnt ihr leiden abmildern zu können...

[mani40]

Antwort auf Beitrag Nr.: 34.701.161 von Strandlaeufer1 am 11.08.08 16:39:42

250 % an einem Tag !!!


hör mal, wenn Du da drüben kaufst kannst Du dies nur bestens, weil die Bank nur nach der dritten Kommastelle limitiert. Insoweit hast Du nach einem EK von 1 Mio Stück das Ding sofort auf 0,0009 $ hoch gerissen, da unglücklicherweise zu diesem Zeitpunkt kein besseres Ask da war. Das kriegt der Makler schon hin. Angenommen der Kurs wird auf 0,0004 getaxt, habe ich allein bei meinem EK von 0,0009 eine Kursexplosion von 125% erreicht.

Das zu Deinem 250% an einem Tag!!!

[fjellraeven]

Xechem targets daily production of 50,000 Nicosan capsules
Written by Emma Ujah, Abuja Bureau Chief
Tuesday, 19 August 2008

Xechem Nigeria Ltd, manufacturers of Nicosan - currently reknowed as the most efficient drug for management sickle cell disease - is boosting output with fresh investments over N1billion for building an additional plant.

Managing Director of the company, Mr Iretiolu Oniyide, told Good Health Weekly during a facility tour of the plant in at the Sheda Science and Technology Complex, Abuja, that the development was made possible following facilities granted the company by the Nigerian Export-Import Bank (NEXIM) and another loan from an American bank that fully guaranteed by the US EX-IM Bank and some Nigerian banks.

He said NEXIM’s N500 million loan and the $4.3 million from the U S was being fully deployed towards accelerating the completion of the new plant which according to him would come on stream in the next six to nine months.

When on stream, Onoyide said Xechem would be able to produce about 50, 000 capsules of Nicosan daily, thereby giving more people living with sickle cell better lease of life.

Onoyide who was one of the Nigerians in the Diaspora who heeded former President Olusegun Obsanjo’s call to return home and help build the Nigerian economy, said he returned from the US to take up the job owing to his firm believe in the country and that Nigeria had the potentials to be great in all respects.

His words: “The only thing that is foreign in the production of Nicosan is the equipment. Even then, some of the equipment are already being fabricated here, locally.”

He said the post-market survey conducted by the company was very encouraging and had been a source of inspiration for him and his team at Xechem which had spurred them towards planning for more ground-breaking drugs.

The MD identified Nicosan as critical to the efforts of Nigeria to achieve the Health goal in the overall Millennium Development Goals (MDGs), as he explained, “to address high mortality in Nigeria, you have to address Nicosan as 80 per cent sickle cell sufferers do not ordinarily live beyond fives years, a trend that Nicosan is effectively reversing.

He said those who take the drug regularly could live normal lives without suffering crises, usually associated with sickle cell and therefore helps them to live and contribute their quota to the growth of society.

Oniyide disclosed that Niger and Nassarawa State governments had been purchasing the drug for distribution in their hospitals at heavily subsidizsd rates for adult patients or given free to children.

Xechem’s boss who was very excited about the drug said all the scientists who were part of the success story of Nicosan deserved National Director-General, SHESTCO, Dr Ayodele Coker, said his organization was prepared to put in place necessary infrastructure within the complex to encourage investors to set science and technology businesses in the complex.

He said Federal government was encouraged by the Xechem success story and therefore urged more businesses to take advantage of the facilities at the complex, located at a serene environment, outside the nation’s capital.

He took journalists round the Gamma irradiation facility within complex which he said has the capacity to address the food storage problems of the nation as the facility could preserve both dry and wet foods for several months.

Vice President of the All Farmers Association of Nigeria (AFAN), Chief Bayo Ajayi, called for the support of Federal and state governments in the NICOSAN project to put smiles on the faces of all sickle cell patients in the country.

Xechem Nigeria started its operation at the National Institute for Pharmaceutical Research and Development (NIPRD) in July 2002 after signing an agreement between NIPRD and XECHEM for research, development, production and worldwide sales and marketing of NICOSAN the Sickle Cell Disease treatment drug, developed by NIPRD scientists.

http://www.vanguardngr.com/index.php?option=com_content&task…

[steini69]

Antwort auf Beitrag Nr.: 34.757.325 von fjellraeven am 19.08.08 06:59:39

na dann mal los ihr helden von xechem, bringt vierteljährlich eure zahlen und zeigt was in euch steckt.

ich habe noch ein paar hundert tausend stücke im depot liegen die nicht verwelken wollen.

steini

[fjellraeven]

New Nigerian plant will boost production of Nicosan


http://www.smartbrief.com/news/aabb/storyDetails.jsp?issueid…

[LoloXP]

Antwort auf Beitrag Nr.: 34.768.983 von fjellraeven am 19.08.08 19:41:03

[future_trader]

was bedeutet jetzt die neueste Pressemiiteilung vom 05. September?

1,6 Mrd. Shares für 740.000 USD Schulden?

Ist das endgültuge Schicksal besiegelt?

[falconara]

Antwort auf Beitrag Nr.: 35.006.998 von future_trader am 06.09.08 15:55:31

was bedeutet jetzt die neueste Pressemiiteilung vom 05. September?

Bitte den Link dazu, möchte gerne diese Pressemiiteilung vom 05. September lesen!
Danke im Voraus
falconara

[future_trader]

Antwort auf Beitrag Nr.: 35.007.005 von falconara am 06.09.08 16:00:16

http://biz.yahoo.com/e/080905/xkem.pk8-k.html

Form 8-K for XECHEM INTERNATIONAL INC

5-Sep-2008

Other Events


Item 8.01 Other Events.

The Company announced today that it has received requests from certain of its Convertible Debenture holders to convert some or all of their debentures to common stock. The Company presently has approximately 2.44 billion shares of common stock outstanding and is authorized to issue up to an additional 1.06 billion shares. Due to the full ratchet adjustments in the debentures, the effective conversion price on the debentures is presently $0.0007 per share, which would enable conversions of approximately $747,000 of principal amount of debentures based upon its current authorized capitalization. The Company intends to provide debenture holders the right to convert up to 10% their debenture principal amount over the next seven business days, so as to equitably allocate conversion rights, based upon available common stock. If any common stock remains available, then additional conversion requests would come on a first come, first served basis until there is no additional authorized common stock. The total principal and accrued unpaid interest of the Company with respect to its April 2007 convertible debentures is approximately $8.4 million. Conversion of the maximum amount of debentures would still leave the Company with significant indebtedness. A substantial risk continues that the Company will need to seek protection in the near future under Chapter 11 of the US Bankruptcy laws, due to the outstanding indebtedness of the Company, its past due accounts payable and multiple litigation. Accordingly, prospective purchasers of the Company's common stock and creditors seeking conversion of indebtedness into common stock should give careful consideration to the effect that a bankruptcy filing would have on their investment in the Company. Additionally, the Company has previously announced that it has received a letter from the Securities and Exchange Commission, dated May 14, 2008, stating that it will seek to deregister the Company's common stock. Although the Company has not received a notice of administrative action as of the date of this Form 8-K, it is expected that such notice will be forthcoming at some time in the future, at which time the Company expects that its stock will be suspended from trading by SEC and that SEC will seek to make the suspension a permanent halt.

Kannst du was dazu sagen? Wäre super interessiert.

[falconara]

Antwort auf Beitrag Nr.: 35.007.021 von future_trader am 06.09.08 16:08:11

dazu bin ich nicht kompetent genug (zu doof)!
Wenn dann könnte zB.: fjellraeven
etwas sagen
mfG

[Helenium]

Antwort auf Beitrag Nr.: 35.007.046 von falconara am 06.09.08 16:21:20

mit meinem wörterbuch habe ich in etwa soviel rausgebrachtohne garantie...)
Es sollen wohl Schuldscheine in aktien umgewandelt werden können. hierzu können die Schuldscheinbesitzer wohl die Schuldverschreibungen mit aktien um über 10% des Wertes erhöhen.
Insgesamt liegen die Schulden wohl bei ca. 8.4 Mio Dollar.
Bei Umwandlung sämtlicher Schulden in aktien werden wohl größere Rechtsstreite befürchtet und es würde nach einem Bankrott aussehen.
Offensichtlich ist wohl ein Schreiben von der SEC an die Companie gegangen(14.05.2008)in dem angekündigt wurde, dass der ASktienhandel wohl eingestellt werden soll. Die Company hat wohl so ein Schreiben nicht erhalten, geht aber davon aus, so etwas in der Zukunft zu erhalten und das die SEC den Handel auf Dauer einstellen wird.
Was ich nicht verstehe, dass heute fast ausschließlich aktien gekauft werden?

[Helenium]

hallohallo,

kann jemand die realtimetabelle reinstellen? die anderen tabellen sind seltsamerweise verschwunden.

vielen dank

[OttomanRosen]

Na, wenn das Mal keine guten Zeichen sind


Medicare - Niger to Spend N7.7 Billion On Children, Women

Daily Trust (Abuja)

NEWS

9 September 2008
Posted to the web 9 September 2008

By Aideloje Ojo
Minna

The Niger State Government is to spend about N7.7 billion annually in providing free medical treatment for children, pregnant women and the old people in the state, the state Commissioner of Health Dr. Isa Vatsa has said.

The commissioner said yesterday in Minna that some hospitals have been selected in the state for the programme.

He explained that government has estimated that over 60 per cent of children in the state would benefit from the free medical care and another 60 per cent of pregnant women would need medical care for ante-natal and post-natal services including treatment of other diseases such as malaria.

He said that for children to access the free medical services their parents must produce their immunisation certificates and birth certificates. This he said was to ensure that the children had not been denied inoculation against the child killer diseases.

Vatsa said the requirement of the birth certificate was also necessary to enable government have comprehensive data on the population of children in order to have effective planning for them.

He said that children with sickle cell diseases were also receiving free drugs in government hospitals while adults with the same problem were paying half of the cost of their drugs in order to check abuse of the process.

Vatsa said the pregnant women were also required to register with any of the public hospitals to enable them have access to the free medical care services and that prescriptions from private hospitals would not be honoured for the programme.

He said that government was also determined to reverse the high maternal mortality rate in the state, and that in this regard government had constructed primary health care clinics and rural hospitals across the state.

He said that government has also constructed seven general hospitals in Mokwa, Mariga, Agaie, Kagara, Sarkin Pawa, Suleja and Kontagora. He added that the hospitals were being equipped with new modern facilities to meet world standard.

http://allafrica.com/stories/printable/200809090899.html" target="_blank" rel="nofollow ugc noopener">http://allafrica.com/stories/printable/200809090899.html

[LoloXP]

[steini69]

[Helenium]

Antwort auf Beitrag Nr.: 35.248.714 von steini69 am 24.09.08 10:25:52

hat es euch allen die sprache verschlagen?
jetzt nur noch komentare "ohne worte"?


...aber was soll man/frau dazu noch sagen.....

[future_trader]

hast du neue Infos? gerne auch per BM!

[steini69]

thread tot?

[Helenium]

Antwort auf Beitrag Nr.: 35.324.051 von steini69 am 29.09.08 11:40:09

"Thread tot?"
denk ich nicht, viele werden nur noch mitlesen, viel neues gibt es ja wohl nicht...
die umsatzzahlen waren in den letzten tagen realtiv hoch...
....nächste woche stehen wir bei 0,1- 0,5 $ !!!!

[LoloXP]

WIRKLICH...ist ja super !!!!!

[wilfonx]

Nicosan Testimonies


"I am twenty five years old now . I have been suffering from sickle cell disease since my early childhood . Over the years, i have tried many types of treatments, which have resulted in little or no success. Then 9 months ago, i as well started using Nicosan. I just had to try Nicosan, after all i have tried nearly everything else . All i can say is, the results are UTTERLY ASTOUNDING !!. Here at last, after so many harrowing years, i can now feel a great deal of relief from all the pain and misery ......FANTASTIC.....!! What more can i say !!.... "

This product has got to be the BEST !!!!!!!

Kindest Regards ,

Jose Eduardo

-USA
-----------------------------------------------

"This is so f***king amazing . Nicosan gave my little son's life a whole new meaning . Diagonised with sickle cell disease a few weeks after his fourth birthday, he has been in and out of hospital countless times. Tears would often roll down my eyes each time he screamed during crises periods. I heard about Nicosan through a close friend ; and later bought the drug on the net. That was six months ago. Today my boy leads an active normal life , he even participates in school sports . No ill health. No pain. No nothing. Its a miracle indeed. I can not explain it. Who can ?..... Thank you. Thank you so damn much !!. "

Armanda Jackson ,

-USA
-----------------------------------------------

"Yes, Nicosan reduce the power of crisis for my wife ......."

Salim Mubarak ,

-Oman

- ----------------------------------------------------




"I have been on Nicosan medication now for a liitle over 8 months . The results have been extraordinary. Before i began the Nicosan medication , i used to have these turbulent crisis almost every fortnight. I have had only one minor crisis which did not last more than a few hours since i began using Nicosan. I can't say enough on how much this drug has helped me and my family."

Femi Johnson ,

-United Kingdom
---------------------------------------------------------

"Nobody could have been more skeptical of Nicosan . Don't blame me. I have tried lots of treatments and "health" products that didn't live up to their claims. It was with these past experiences in mind that i once again "experimented" with Nicosan. I have been taking Nicosan pills now for 12 consecutive weeks , and the effect is quite phenomenal.I think this product is gonna save a lot of lives .Nicosan rocks for real ."

Bill Freeman,

-USA.
-----------------------------------------------

"My name is Susan, and i live in PA . I just want to say that am quite enthused about the effects of this Nigerian drug called Nicosan. I have been having crisis for as long as i can remember . I particularly dread the coming of winter because that is when things really get bad with my health. I have been taking Nicosan since August last year. The good news is that i have not experienced severe crisis uptil this moment .I confess that am one of the world's foremost skeptics, but this time i have been converted to a true believer in this stuff .Thanks very much, and God bless you."

Susan Bayou,

-USA.
----------------------------------------------
"My name is Michael Fadiga . I started using Nicosan medication sometime in October, 2007 . I was rather surprised that after taking Nicosan for only one month and the frequent crisis stopped occurring. My health is now great . I have gained some weight (26 lbs) . Most folks now say that i look good . Deep down i know that i feel good , i don't need nobody to tell me that .............. Thanks a lot . "

Michael Fadiga ,

-USA.

---------------------------------------------------------------------

"Wow !, I can't believe it !!. I frequently had terrible crises in the past . This is now the fourth straight month without me experiencing crises of any sort .

Thanks folks.

V. Sanjay ,

- Canada
-------------------------------------------------

[steini69]

Antwort auf Beitrag Nr.: 35.377.856 von wilfonx am 02.10.08 12:12:04

die in den westlichen ländern, die durch nicosan linderung der krankheit erfahren sollten alle mal fleißig aktien von xechem kaufen dann haben se nicht nur linderung durch die medizin sondern helfen auch noch dass es die medizin weiter geben wird.

wenn firma tot dann auch medikament erst mal wieder vom markt dann auch krankheit wieder schlimm.

steini

[LoloXP]

Heute wird ein guter Tag...
2000%-3000%

[falconara]

Antwort auf Beitrag Nr.: 35.626.967 von LoloXP am 20.10.08 00:49:06

häää
was is' los?????

[Helenium]

Antwort auf Beitrag Nr.: 35.626.967 von LoloXP am 20.10.08 00:49:06

2000%-3000% war gestern wohl noch nix,
wird aber heute...
mind. 5000%

wir sind ja bescheiden....

[falconara]

Antwort auf Beitrag Nr.: 35.639.350 von Helenium am 21.10.08 09:40:04

..seid Ihr "alle" im Delierium?

[aamann]

aktueller Kurs: 0,00

Irgendwas würde ich schon gern mal wieder hören von der Bude...

[steini69]

Antwort auf Beitrag Nr.: 35.764.904 von aamann am 30.10.08 15:36:24

0,0001 usd

[future_trader]

weiss jemand hier den aktuellen stand?

werden sie von der börse genommen?

wäre dankbar für neuigkeiten!!!

[boss1970]

Antwort auf Beitrag Nr.: 35.787.666 von future_trader am 01.11.08 10:31:56

Ich glaube die Leute von xechem, müssen noch mal wach gerüttelt werden.
viel spass dabei

[Helenium]

Antwort auf Beitrag Nr.: 35.900.138 von boss1970 am 10.11.08 11:23:57

hallo , meinst du mit spass etwa
"weniger ist mehr" ?
dann haben hier alle die noch drin sind einen riesenspass,
läßt sich eigentlich gar nicht beschreiben..

also dann bis zum börsengang oder zur übernahme durch einen pharmariesen....

[xero1972]

chapter 11 ! ... mein beileid, leute ...

[xero1972]

XECHEM INTL INC (U-XKEM) - News Release
Xechem International, Inc. and Xechem, Inc. Files Chapter 11 to Protect Assets as It Addresses Financial and Legal Challenges

2008-11-10 12:58 ET - News Release


EDISON, NJ -- (MARKET WIRE) -- 11/10/08


Xechem International, Inc. (PINKSHEETS: XKEM) (the "Company" or "Xechem") announced today, November 10, 2008, that it and one of its subsidiaries, Xechem, Inc., filed voluntary petitions for relief under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Northern District of Illinois (the "Bankruptcy Court") to suspend all litigation and to restructure its debt. The Company intends to work with all of its constituencies to reach mutually acceptable resolutions and to exit bankruptcy as expeditiously as possible. Xechem's operations are expected to continue as normal throughout the bankruptcy process, while the Company executes on its reorganization plans. Xechem's other subsidiaries are not part of this Chapter 11 filing. Xechem's Nigerian subsidiary, Xechem Pharmaceuticals Nigeria Limited, will continue its normal operations of the manufacturing and sale of NICOSAN(TM), a drug approved for marketing in Nigeria for the management of Sickle Cell Disease.

"As a result of litigation and litigation expenses arising from the law suits of former officers, employees and consultants of the Company, as well as third party lawsuits, and to protect the operations of our Nigerian subsidiary from default judgments and creditors, it became necessary to seek the protection of the Court. We have taken and will continue to take the necessary steps to protect, strengthen and expand our operations in Nigeria," said Dr. Robert Swift, Chief Oversight Officer of Xechem International, Inc. "After careful consideration of all available alternatives, the Company's Board of Directors determined that filing for Chapter 11 was a necessary and prudent step that allows us to operate our business without the threat of litigation that could have impaired or interrupted our Nigerian operation while continuing to implement a debt restructuring in a controlled, Court-supervised environment."

The Company expects to fund ongoing operations including payment of employee wages and benefits and payments to vendors for both goods and services provided during the Chapter 11 case, from available cash, cash generated by its Nigerian subsidiary, sale of assets and if necessary to seek a commitment for debtor-in-possession (DIP) financing. Available cash, cash from operations in Nigeria, sale of assets and the possible DIP financing will be used to fund the Company, subject to court approval, where necessary. In addition, the Company has commenced restructuring discussions with its unsecured creditors for conversion of debt of the Company into equity through a plan of reorganization, which if successful, would result in material deleveraging of the Company's balance sheet.

Dr. Swift continued, "Filing for Chapter 11 is never an easy decision, however, we view this process as an important step in our ongoing strategic restructuring. We expect to emerge from bankruptcy as a stronger, more able company, well positioned for growth and enhanced profitability. We are proud of the progress we have made to commercialize NICOSAN(TM) in Nigeria and look forward to commercializing NICOSAN worldwide."

Xechem has retained Heller, Draper, Hayden, Patrick, & Horn, L.L.C., a bankruptcy and insolvency law firm, to assist the Company throughout the restructuring process.

The Company and its domestic subsidiary have filed their voluntary Chapter 11 petitions in the United States Bankruptcy Court for the Northern District of Illinois. Xechem International, Inc. case has been assigned case number 08-30513 and Xechem, Inc. has been assigned case number 08-30512. Additional information about the restructuring will be made available at the parent Company's website http://www.xechem.com within the next three weeks.

[LoloXP]

Xechem's other subsidiaries are not part of this Chapter 11 filing. Xechem's Nigerian subsidiary, Xechem Pharmaceuticals Nigeria Limited, will continue its normal operations of the manufacturing and sale of NICOSAN(TM), a drug approved for marketing in Nigeria for the management of Sickle Cell Disease.

[freshmeat]

hallo zusammen,
kann das sein? da jemand oder mehrere in den letzten zwei tagen über 100 Mio Aktien eingesammelt?

Evtl. wird jemand mehr wissen als wir :-( ich hoffe wir müssen nicht dumm sterben.

[Helenium]

100 Stück zu 0,0002 C ? = 2 Cent

Das ist irgendeine Mitteilung von einem Händler, "es ist was faul im Staate Dänemark!"

[Strandlaeufer1]

Geheimsprache der Market Maker:

100 = I need shares
200 = I need shares badly, but do not take it down
300 = Take the price down to get shares
usw

SL1

[infight]

[Strandlaeufer1]

Stand heute 18 Uhr:
18 mio nur Käufe !!
SL1

[infight]

Antwort auf Beitrag Nr.: 35.950.072 von Strandlaeufer1 am 14.11.08 18:37:25

weiss du, wieviel auf der 1 noch zum verkauf stehen? ich hatee noch nie so einen fall (gott sei dank).

[infight]

Bid 0.0001
Ask 0.0001
Volume 49,327,500

[Egobuster]

Antwort auf Beitrag Nr.: 35.951.503 von infight am 14.11.08 21:44:31

hmmm kann mir einer erklären was das heisst? warum wird da so gekauft?
Ich hab mich die letzten Wochen auf andere Aktien konzentriert meint ihr bei xechem geht noch was, oder kann man xechem nun vollends abschreiben?

[Helenium]

Hallolo,

Mitteilung meiner Bank von heute:
Die gesellschaft hat beim gericht einen Antrag gem. Chapter XIes Federal Bankrupty Act. eingereicht.
Dies bedeutet zunächst, dass unter dem Schutz dieses gesetzes eine Sanierung der Gesellschaft versucht wird. Ist die Reorganisation nicht erfolgreich, geht die Gesellschaft in Konkurs.
Vielleicht kauft sich ja jemand groß ein um bei der Sanierung zu helfen...

ich wünsch uns allen viel Glück...

[infight]

interessante diskussion im ihub.

[infight]

Change ◊ 0
Bid -
Ask 0.0001
Volume 20,460,000

[infight]

!

Dieser Beitrag wurde moderiert. Grund: Spammposting

[infight]

!

Dieser Beitrag wurde moderiert. Grund: Spammposting

[infight]

jemand da?

[boss1970]

Antwort auf Beitrag Nr.: 35.997.178 von infight am 18.11.08 22:25:06

was gibt es neues in diesem Krimi???????????????????

[infight]

Bankruptcy leaves indigenous sickle cell treatment in jeopardy
Adole Hassan


21 November 2008 | EN



Warren Grant Magnuson Clinical Centre
[ABUJA] A pioneering attempt to commercialise an indigenous treatment for sickle cell anaemia is in serious trouble after the US-based company owning the rights to its development filed for bankruptcy.

Xechem International, whose five-year involvement with the drug, Nicosan, in Nigeria has been tainted by recent allegations of fraud and corruption, this month (10 November) filed voluntary petitions for relief under Chapter 11 of the US Bankruptcy code, for itself and one of its six subsidiaries.

The announcement followed an angry statement issued by shareholders a few days earlier (4 November) accusing Xechem International's chief oversight officer, Robert Swift, of "colossal failures" of management and "systematic destruction" of the parent company.

Nicosan (formerly Niprisan) is based on extracts from West African plants and had been known to generations of a Nigerian family as an effective treatment for sickle cell anaemia.

Around 12 million people suffer from the painful genetic illness. It has been labelled "probably the most neglected serious public health disorder in Africa" by Charles Wambebe, chief executive officer of the International Biomedical Research Institute in Abuja, Nigeria.

A controversial deal

Initially, the family who owned the recipe drew up a Memorandum of Understanding for its development with Nigeria's National Institute for Pharmaceutical Research and Development. This pioneering agreement has been widely cited as a case study in "benefit sharing" — allowing vulnerable groups to have a stake in the profits made from commercialising indigenous products.

In 2003, in a controversial move, Xechem bought the rights to develop Nicosan. By February this year its subsidiary, Xechem Nigeria, said it was producing some 50,000 capsules a year (see Sickle cell drug mired in controversy).

But the following month (March) a fraud complaint was brought before Nigeria's Economic and Financial Crime Commission (EFCC) against Xechem Nigeria. The complainant alleged that US$3.5 million of public funding from the Nigerian government, which was supposed to have been spent on drug manufacture, had been misused.

Xechem had also borrowed nearly US$4 million from a Nigerian bank and US$4 million from a US bank. The destination of these loans has also been questioned.

In June, following an investigation by SciDev.Net that revealed a complex array of issues relating to Xechem, the EFCC announced an investigation into the affair. But, to date, there has been no outward sign of an investigation.

Going public

This month, shareholders said they were making their grievances public because "numerous" attempts to contact members of Xechem's international board of directors had been unsuccessful.

They cited a 99 per cent reduction in the price of the Xechem International Common Stock from US$0.02 in July 2007 to US$0.0002 in November 2008.

They also said that the company had failed for 12 months to retrieve from customs in Lagos US$4.3 million in new equipment purchased for Xechem's manufacturing facility in Abuja and US$2 million in equipment removed from Xechem's former facility in New Brunswick, New Jersey.

There had been "no movement on Food and Drug Administration (FDA) approvals in 16 months; … the termination of planned clinical trials for Xechem's sole marketable product, Nicosan; and numerous allegations against the managing director of Xechem Nigeria, with no apparent investigation or company update into the accuracy of those allegations'.

The shareholders called for the resignation of Swift and demanded an immediate shareholders meeting, noting that bankruptcy would be "an action that will destroy the investments of the shareholders'.

Separately, some have also called for the reinstatement of Ramesh Pandey, the founder of Xechem International, who lost his position as president and chief executive officer last summer following the injection of a new round of capital in the company by a group of investors.

A difficult decision

Swift said in the bankruptcy statement: "filing for Chapter 11 is never an easy decision, however, we view this process as an important step in our ongoing strategic restructuring. We expect to emerge from bankruptcy as a stronger, more able company, well positioned for growth and enhanced profitability."

The company said its financial problems had arisen "as a result of litigation and litigation expenses arising from the lawsuits of former officers, employees and consultants of the company — as well as third party lawsuits — and to protect the operations of our Nigerian subsidiary from default judgments and creditors, it became necessary to seek the protection of the court".

It added that its Nigerian subsidiary "will continue its normal operations".

But a visit by SciDev.Net to the main production site for Nicosan, in Abuja, revealed that activities have ground to a halt.

A staff member — who spoke to SciDev.Net on condition of anonymity — said that the managing director of Xechem Nigeria, Iretiolu Oniyide, had been "elusive" since SciDev.Net broke its story in June. Oniyide denied any wrongdoing in an interview with SciDev.Net earlier this year.

"We go about our work here looking behind us, thinking the team from EFCC has finally arrived. We hope they come before this place finally grinds to a halt,' the staff member said.

Meanwhile a proposal by minister of science and technology Grace Ekpiwhre to set up a committee to investigate Xechem Nigeria, has been dropped after a ministerial meeting decided the allegations were "baseless and untrue", according to a source.
Bankruptcy leaves indigenous sickle cell treatment in jeopardy
Adole Hassan


21 November 2008 | EN


These distinctive, sickle-shaped blood cells spell an early death for millions of sufferers – and Nicosan aims to prevent this.

Warren Grant Magnuson Clinical Centre
[ABUJA] A pioneering attempt to commercialise an indigenous treatment for sickle cell anaemia is in serious trouble after the US-based company owning the rights to its development filed for bankruptcy.

Xechem International, whose five-year involvement with the drug, Nicosan, in Nigeria has been tainted by recent allegations of fraud and corruption, this month (10 November) filed voluntary petitions for relief under Chapter 11 of the US Bankruptcy code, for itself and one of its six subsidiaries.

The announcement followed an angry statement issued by shareholders a few days earlier (4 November) accusing Xechem International's chief oversight officer, Robert Swift, of "colossal failures" of management and "systematic destruction" of the parent company.

Nicosan (formerly Niprisan) is based on extracts from West African plants and had been known to generations of a Nigerian family as an effective treatment for sickle cell anaemia.

Around 12 million people suffer from the painful genetic illness. It has been labelled "probably the most neglected serious public health disorder in Africa" by Charles Wambebe, chief executive officer of the International Biomedical Research Institute in Abuja, Nigeria.

A controversial deal

Initially, the family who owned the recipe drew up a Memorandum of Understanding for its development with Nigeria's National Institute for Pharmaceutical Research and Development. This pioneering agreement has been widely cited as a case study in "benefit sharing" — allowing vulnerable groups to have a stake in the profits made from commercialising indigenous products.

In 2003, in a controversial move, Xechem bought the rights to develop Nicosan. By February this year its subsidiary, Xechem Nigeria, said it was producing some 50,000 capsules a year (see Sickle cell drug mired in controversy).

But the following month (March) a fraud complaint was brought before Nigeria's Economic and Financial Crime Commission (EFCC) against Xechem Nigeria. The complainant alleged that US$3.5 million of public funding from the Nigerian government, which was supposed to have been spent on drug manufacture, had been misused.

Xechem had also borrowed nearly US$4 million from a Nigerian bank and US$4 million from a US bank. The destination of these loans has also been questioned.

In June, following an investigation by SciDev.Net that revealed a complex array of issues relating to Xechem, the EFCC announced an investigation into the affair. But, to date, there has been no outward sign of an investigation.

Going public

This month, shareholders said they were making their grievances public because "numerous" attempts to contact members of Xechem's international board of directors had been unsuccessful.

They cited a 99 per cent reduction in the price of the Xechem International Common Stock from US$0.02 in July 2007 to US$0.0002 in November 2008.

They also said that the company had failed for 12 months to retrieve from customs in Lagos US$4.3 million in new equipment purchased for Xechem's manufacturing facility in Abuja and US$2 million in equipment removed from Xechem's former facility in New Brunswick, New Jersey.

There had been "no movement on Food and Drug Administration (FDA) approvals in 16 months; … the termination of planned clinical trials for Xechem's sole marketable product, Nicosan; and numerous allegations against the managing director of Xechem Nigeria, with no apparent investigation or company update into the accuracy of those allegations''.

The shareholders called for the resignation of Swift and demanded an immediate shareholders meeting, noting that bankruptcy would be "an action that will destroy the investments of the shareholders''.

Separately, some have also called for the reinstatement of Ramesh Pandey, the founder of Xechem International, who lost his position as president and chief executive officer last summer following the injection of a new round of capital in the company by a group of investors.

A difficult decision

Swift said in the bankruptcy statement: "filing for Chapter 11 is never an easy decision, however, we view this process as an important step in our ongoing strategic restructuring. We expect to emerge from bankruptcy as a stronger, more able company, well positioned for growth and enhanced profitability."

The company said its financial problems had arisen "as a result of litigation and litigation expenses arising from the lawsuits of former officers, employees and consultants of the company — as well as third party lawsuits — and to protect the operations of our Nigerian subsidiary from default judgments and creditors, it became necessary to seek the protection of the court".

It added that its Nigerian subsidiary "will continue its normal operations".

But a visit by SciDev.Net to the main production site for Nicosan, in Abuja, revealed that activities have ground to a halt.

A staff member — who spoke to SciDev.Net on condition of anonymity — said that the managing director of Xechem Nigeria, Iretiolu Oniyide, had been "elusive" since SciDev.Net broke its story in June. Oniyide denied any wrongdoing in an interview with SciDev.Net earlier this year.

"We go about our work here looking behind us, thinking the team from EFCC has finally arrived. We hope they come before this place finally grinds to a halt,'' the staff member said.

Meanwhile a proposal by minister of science and technology Grace Ekpiwhre to set up a committee to investigate Xechem Nigeria, has been dropped after a ministerial meeting decided the allegations were "baseless and untrue", according to a source.
Bankruptcy leaves indigenous sickle cell treatment in jeopardy
Adole Hassan


21 November 2008 | EN


These distinctive, sickle-shaped blood cells spell an early death for millions of sufferers – and Nicosan aims to prevent this.

Warren Grant Magnuson Clinical Centre
[ABUJA] A pioneering attempt to commercialise an indigenous treatment for sickle cell anaemia is in serious trouble after the US-based company owning the rights to its development filed for bankruptcy.

Xechem International, whose five-year involvement with the drug, Nicosan, in Nigeria has been tainted by recent allegations of fraud and corruption, this month (10 November) filed voluntary petitions for relief under Chapter 11 of the US Bankruptcy code, for itself and one of its six subsidiaries.

The announcement followed an angry statement issued by shareholders a few days earlier (4 November) accusing Xechem International's chief oversight officer, Robert Swift, of "colossal failures" of management and "systematic destruction" of the parent company.

Nicosan (formerly Niprisan) is based on extracts from West African plants and had been known to generations of a Nigerian family as an effective treatment for sickle cell anaemia.

Around 12 million people suffer from the painful genetic illness. It has been labelled "probably the most neglected serious public health disorder in Africa" by Charles Wambebe, chief executive officer of the International Biomedical Research Institute in Abuja, Nigeria.

A controversial deal

Initially, the family who owned the recipe drew up a Memorandum of Understanding for its development with Nigeria's National Institute for Pharmaceutical Research and Development. This pioneering agreement has been widely cited as a case study in "benefit sharing" — allowing vulnerable groups to have a stake in the profits made from commercialising indigenous products.

In 2003, in a controversial move, Xechem bought the rights to develop Nicosan. By February this year its subsidiary, Xechem Nigeria, said it was producing some 50,000 capsules a year (see Sickle cell drug mired in controversy).

But the following month (March) a fraud complaint was brought before Nigeria's Economic and Financial Crime Commission (EFCC) against Xechem Nigeria. The complainant alleged that US$3.5 million of public funding from the Nigerian government, which was supposed to have been spent on drug manufacture, had been misused.

Xechem had also borrowed nearly US$4 million from a Nigerian bank and US$4 million from a US bank. The destination of these loans has also been questioned.

In June, following an investigation by SciDev.Net that revealed a complex array of issues relating to Xechem, the EFCC announced an investigation into the affair. But, to date, there has been no outward sign of an investigation.

Going public

This month, shareholders said they were making their grievances public because "numerous" attempts to contact members of Xechem's international board of directors had been unsuccessful.

They cited a 99 per cent reduction in the price of the Xechem International Common Stock from US$0.02 in July 2007 to US$0.0002 in November 2008.

They also said that the company had failed for 12 months to retrieve from customs in Lagos US$4.3 million in new equipment purchased for Xechem's manufacturing facility in Abuja and US$2 million in equipment removed from Xechem's former facility in New Brunswick, New Jersey.

There had been "no movement on Food and Drug Administration (FDA) approvals in 16 months; … the termination of planned clinical trials for Xechem's sole marketable product, Nicosan; and numerous allegations against the managing director of Xechem Nigeria, with no apparent investigation or company update into the accuracy of those allegations''.

The shareholders called for the resignation of Swift and demanded an immediate shareholders meeting, noting that bankruptcy would be "an action that will destroy the investments of the shareholders''.

Separately, some have also called for the reinstatement of Ramesh Pandey, the founder of Xechem International, who lost his position as president and chief executive officer last summer following the injection of a new round of capital in the company by a group of investors.

A difficult decision

Swift said in the bankruptcy statement: "filing for Chapter 11 is never an easy decision, however, we view this process as an important step in our ongoing strategic restructuring. We expect to emerge from bankruptcy as a stronger, more able company, well positioned for growth and enhanced profitability."

The company said its financial problems had arisen "as a result of litigation and litigation expenses arising from the lawsuits of former officers, employees and consultants of the company — as well as third party lawsuits — and to protect the operations of our Nigerian subsidiary from default judgments and creditors, it became necessary to seek the protection of the court".

It added that its Nigerian subsidiary "will continue its normal operations".

But a visit by SciDev.Net to the main production site for Nicosan, in Abuja, revealed that activities have ground to a halt.

A staff member — who spoke to SciDev.Net on condition of anonymity — said that the managing director of Xechem Nigeria, Iretiolu Oniyide, had been "elusive" since SciDev.Net broke its story in June. Oniyide denied any wrongdoing in an interview with SciDev.Net earlier this year.

"We go about our work here looking behind us, thinking the team from EFCC has finally arrived. We hope they come before this place finally grinds to a halt,'' the staff member said.

Meanwhile a proposal by minister of science and technology Grace Ekpiwhre to set up a committee to investigate Xechem Nigeria, has been dropped after a ministerial meeting decided the allegations were "baseless and untrue", according to a source.
Bankruptcy leaves indigenous sickle cell treatment in jeopardy
Adole Hassan


21 November 2008 | EN


These distinctive, sickle-shaped blood cells spell an early death for millions of sufferers – and Nicosan aims to prevent this.

Warren Grant Magnuson Clinical Centre
[ABUJA] A pioneering attempt to commercialise an indigenous treatment for sickle cell anaemia is in serious trouble after the US-based company owning the rights to its development filed for bankruptcy.

Xechem International, whose five-year involvement with the drug, Nicosan, in Nigeria has been tainted by recent allegations of fraud and corruption, this month (10 November) filed voluntary petitions for relief under Chapter 11 of the US Bankruptcy code, for itself and one of its six subsidiaries.

The announcement followed an angry statement issued by shareholders a few days earlier (4 November) accusing Xechem International's chief oversight officer, Robert Swift, of "colossal failures" of management and "systematic destruction" of the parent company.

Nicosan (formerly Niprisan) is based on extracts from West African plants and had been known to generations of a Nigerian family as an effective treatment for sickle cell anaemia.

Around 12 million people suffer from the painful genetic illness. It has been labelled "probably the most neglected serious public health disorder in Africa" by Charles Wambebe, chief executive officer of the International Biomedical Research Institute in Abuja, Nigeria.

A controversial deal

Initially, the family who owned the recipe drew up a Memorandum of Understanding for its development with Nigeria's National Institute for Pharmaceutical Research and Development. This pioneering agreement has been widely cited as a case study in "benefit sharing" — allowing vulnerable groups to have a stake in the profits made from commercialising indigenous products.

In 2003, in a controversial move, Xechem bought the rights to develop Nicosan. By February this year its subsidiary, Xechem Nigeria, said it was producing some 50,000 capsules a year (see Sickle cell drug mired in controversy).

But the following month (March) a fraud complaint was brought before Nigeria's Economic and Financial Crime Commission (EFCC) against Xechem Nigeria. The complainant alleged that US$3.5 million of public funding from the Nigerian government, which was supposed to have been spent on drug manufacture, had been misused.

Xechem had also borrowed nearly US$4 million from a Nigerian bank and US$4 million from a US bank. The destination of these loans has also been questioned.

In June, following an investigation by SciDev.Net that revealed a complex array of issues relating to Xechem, the EFCC announced an investigation into the affair. But, to date, there has been no outward sign of an investigation.

Going public

This month, shareholders said they were making their grievances public because "numerous" attempts to contact members of Xechem's international board of directors had been unsuccessful.

They cited a 99 per cent reduction in the price of the Xechem International Common Stock from US$0.02 in July 2007 to US$0.0002 in November 2008.

They also said that the company had failed for 12 months to retrieve from customs in Lagos US$4.3 million in new equipment purchased for Xechem's manufacturing facility in Abuja and US$2 million in equipment removed from Xechem's former facility in New Brunswick, New Jersey.

There had been "no movement on Food and Drug Administration (FDA) approvals in 16 months; … the termination of planned clinical trials for Xechem's sole marketable product, Nicosan; and numerous allegations against the managing director of Xechem Nigeria, with no apparent investigation or company update into the accuracy of those allegations''.

The shareholders called for the resignation of Swift and demanded an immediate shareholders meeting, noting that bankruptcy would be "an action that will destroy the investments of the shareholders''.

Separately, some have also called for the reinstatement of Ramesh Pandey, the founder of Xechem International, who lost his position as president and chief executive officer last summer following the injection of a new round of capital in the company by a group of investors.

A difficult decision

Swift said in the bankruptcy statement: "filing for Chapter 11 is never an easy decision, however, we view this process as an important step in our ongoing strategic restructuring. We expect to emerge from bankruptcy as a stronger, more able company, well positioned for growth and enhanced profitability."

The company said its financial problems had arisen "as a result of litigation and litigation expenses arising from the lawsuits of former officers, employees and consultants of the company — as well as third party lawsuits — and to protect the operations of our Nigerian subsidiary from default judgments and creditors, it became necessary to seek the protection of the court".

It added that its Nigerian subsidiary "will continue its normal operations".

But a visit by SciDev.Net to the main production site for Nicosan, in Abuja, revealed that activities have ground to a halt.

A staff member — who spoke to SciDev.Net on condition of anonymity — said that the managing director of Xechem Nigeria, Iretiolu Oniyide, had been "elusive" since SciDev.Net broke its story in June. Oniyide denied any wrongdoing in an interview with SciDev.Net earlier this year.

"We go about our work here looking behind us, thinking the team from EFCC has finally arrived. We hope they come before this place finally grinds to a halt,'' the staff member said.

Meanwhile a proposal by minister of science and technology Grace Ekpiwhre to set up a committee to investigate Xechem Nigeria, has been dropped after a ministerial meeting decided the allegations were "baseless and untrue", according to a source.

[infight]

!

Dieser Beitrag wurde moderiert.

[infight]

Antwort auf Beitrag Nr.: 36.043.796 von infight am 22.11.08 11:05:27

grüsse von bua, der mir diese zusammenstellung geschickt hat.

[infight]

!

Dieser Beitrag wurde moderiert. Grund: auf eigenen Wunsch des Users

[infight]

!

Dieser Beitrag wurde moderiert. Grund: auf eigenen Wunsch des Users

[infight]

vielen dank an den user bua321 für diese informationen.

[boss1970]

kann mir bitte mal einer erklären, was da genau passiert im moment

[infight]

Change ◊ 0
Bid 0.0001
Ask 0.0002
Volume 35,194,425
Day's Range 0.0001 - 0.0002

Ob es hier nochmal ein Comeback gibt?

Schwer zu glauben...

[boss1970]

Antwort auf Beitrag Nr.: 36.127.939 von infight am 02.12.08 00:17:13

ich finde die könnten ruhig mal den neusten stand der dinge mal wieder durchsickern lassen, es wird mal wieder zeit für neue info

[steini69]

Antwort auf Beitrag Nr.: 36.128.470 von boss1970 am 02.12.08 09:00:33

Hi,

wenn ich das auf ihub richtig einschätzen kann sammeln sich derzeit viele xechem aktionäre um mit juristischer unterstützung gegen swift und co vorzugehen.

scheinbar hat swift xechem absichtlich an die wand gefahren - so vermuten die aufgrund diverser recherchen - um sich billigst die rechte an 5hmf (neben nicosan die eigentliche hoffnung von xechem auf erfolg) zu sichern (war wohl durch ihn als sicherheit für angeblich von ihm an xechem geliehenes geld eigenmächtig vereinbart worden) - und dann mit 5hmf einen neuanfang ohne xechem zu starten und gleich auch nicosan mitzunehmen.

da sind angeblich verstrickungen des gesamten swift clans aufgeflogen und nun wird versucht mit psychologischem druck auf pandey und burg eine art absetzung von swift zu erreichen um den letzten strohhalm noch zu ergreifen und pandey wieder die macht an xechem zurückzugeben

jedenfalls sind bereits kontakte zu juristen und auch zu medien hergestellt worden um dem thema eine nötige brisanz aufzuerlegen und um druck auf swift auszuüben. sie wollen wenigstens die verantwortlichen im knast sehen um sagen zu können wir haben alles versucht, auch wenn unser geld evtl. komplett verloren ist.

mal sehen was daraus wird, ich habe nicht mehr viele aktien (noch ca. 150.000), auch wenn es insgesamt ca. 5.000 eur waren die ich in den 2-3 jahren durch xechem versiebt habe, ich habs abgeschrieben und daher ist jeder positive erfolg dieser aktion - auch wenn ich ehrlich gesagt nicht mehr dran glaube - auch für mich erfreulich.

steini

[boss1970]

Antwort auf Beitrag Nr.: 36.135.702 von steini69 am 03.12.08 08:34:49

danke für deine einschätzung,dann will ich mal hoffen das sich swift kräftig daran verschluck, vielleicht helfen ihm bestimmt ja auch noch andere sich daran zu verschlucken

[boss1970]

Antwort auf Beitrag Nr.: 36.037.411 von infight am 21.11.08 19:39:53

es ist aber ganz schön ruhig geworden hier, kann mir mal einer was neues sagen oder zumindest sagen wo man was neues lesen kann. So langsam müssen die doch aussagen treffen können.

[boss1970]

Antwort auf Beitrag Nr.: 36.153.184 von boss1970 am 05.12.08 11:46:14

der der versucht den Kurs zu drücken mit 0,0001 der soll ruhig weitermachen ich kaufe die alle auf. Auf geht´s

[steini69]

heute scheint das hearing vor gericht zu sein wegen chapter 11.

auf ihub warten se alle gespannt, was dabei rauskommen wird.

also weiter warten und die finger nicht vom letzten strohhalm nehmen.

steini

wers noch nicht getan hat, sollte seine stückzahl die er an xkem noch hält mit dem vollen namen an folgende mail senden, er sammelt die summen um damit druck auszuüben:


[e-mail]

- Anzahl
- Voller name
- e-mail adresse

[physik]

Antwort auf Beitrag Nr.: 36.192.297 von steini69 am 12.12.08 01:24:20

die User auf iHub sind mir überwiegend suspekt.
An erster Stelle ist da drifter, der immerzu die Seite wechselt und darauf verweist wie Recht er hat und was für gute Beziehungen.
Er war einer der ersten, die Pandey verdammten, er ist nun einer derer, die ihn zurückhaben wollen.

Und im großen und ganzen sieht es fürchterlich aus:
Swift hat wohl einen großen Coup eingefädelt, der ihn mit der Lizenz für Nicosan davonziehen lassen wird. M.E. wird Xechem als leere Hülle untergehen und Swift macht in einem neuen Unternehmen mit Nicosan Riesengewinne.

Die iHub-Bevölkerung stürzt sich inzwischen auf den nächsten Scam. Sie kaufen jetzt alle den sogenannten Forex-robot - ein Programm, das automatisch an der Börse handelt und angeblich nie Verluste macht.

Wer sich das Teil mal etwas genauer ansieht merkt die einfache Technik. Es wird an der Forex gekauft und bei Gewinnen von 7 punkten verkauft. Fällt der Wert, wird nicht verkauft, nie. Bis es wieder 7 Punkte im Plus ist.
Dadurch tauchen Verluste nie auf - sie sind aber in den Büchern. Ein ganz großer Betrug.
(es lohnt sich, danach zu googlen - es gibt Berichte zu diesem und ähnlichen Programmen).

[physik]

Antwort auf Beitrag Nr.: 36.188.965 von boss1970 am 11.12.08 16:50:43

an welcher Börse kaufst Du denn? Über welchen Broker?
Die meisten Broker ermöglichen keinerlei Handel in diesem Wert.

[falconara]

!

Dieser Beitrag wurde moderiert.

[falconara]

Antwort auf Beitrag Nr.: 36.192.297 von steini69 am 12.12.08 01:24:20

hallo steini!
BITTE,ANTWORT!!!
wer oder was ist :
[e-mail]

- Anzahl
- Voller name
- e-mail adresse
wer bekäme da diese 3 Angaben in die Hände???

mfG
falconara

[boss1970]

Antwort auf Beitrag Nr.: 36.193.416 von physik am 12.12.08 09:55:28

Handelsplatz New York und das ganze wird über meine Hausbank abgewickelt.

Ich weiß das die Lage ziemlich gereizt ist und darum wollen wir mal das beste hoffen.

[steini69]

Hier mal ein kurzes update aus der gestrigen anhörung von lmf:

Quick update from the hearing today...

Dr. Swift had to answer questions under oath for about 20 creditors and shareholders. We were able to get three shareholders on the call and had the individual we would like to retain as an attorney, who was in the room in Chicago. He asked the first batch of questions for about 10 minutes and then others asked questions for a total of about 90 minutes. Fiat asked quite a few great questions during the process as did many others (mostly bond holders, some attorneys). At the end of the day we learned:

1). They are in negotiations to sell Xechem Nigeria.

2). They acted like they have no plan other than to sell things and see what they can do after that. They were pressed to answer but that's all they would disclose.

3). When asked about his successes over the last 17 months the only thing Dr. Swift came up with was an improved production process. He stated that he's spent 5 months in Nigeria.

4). They intend on selling the rights to Nicosan in Nigeria only if the Xechem Nigeria sale goes through, but keep the rights for the rest of the world (when asked if that would be OK with NIPRD they had no answer).

There will be an audio of the hearing released, when I get the CD I'll do what I can to post it in such a way that everyone will be able to hear it.

If you haven't contacted me with share numbers and contact info, please do so, we'll need all the support we can get with the attorney fees and a few other things that are in the works...

[steini69]

Antwort auf Beitrag Nr.: 36.193.378 von physik am 12.12.08 09:52:23

dem drifter hab ich schon meine meinung per ihub message zukommen lassen. ein besserwisser der sich nur selber beweihräuchern kann und immer hinter heralles schon vorher gewußt.

über ihn kann ich eigentlich nur noch lachen.

wichtig für mich wäre, dass es swift eben nicht schafft, einen leeren mantel zurück zulassen sondern der letzte funken hoffnung der noch besteht, genutzt wird um das feuer wieder zu entfachen, obwohl ich ehrlich gesagt auch nicht mehr wirklich daran glauben mag.

wir werden sehen

steini

[boss1970]

Antwort auf Beitrag Nr.: 36.195.777 von steini69 am 12.12.08 14:11:19

hallo ich hoffe die gemüter haben sich ein bisschen beruhigt.
kann mir denn mal einer den stand der dinge durchgeben.

danke im voraus

[reitenhammer]

Antwort auf Beitrag Nr.: 36.195.777 von steini69 am 12.12.08 14:11:19

hallo ich heiße hugo und würde gerne wissen wo man news über dieses Unternehmen bekommt. ich bin über jede hilfe sehr dankbar.

es ist schade das in diesem forum nicht mehr geschrieben wird.

grüsse und danke

hugo

[aamann]

Antwort auf Beitrag Nr.: 36.321.000 von reitenhammer am 07.01.09 08:34:42

hallo hugo und alle anderen verbliebenen!

letzte info (vorgestern aus USA per mail von Monty erhalten) ist, dass einige Aktionäre das Ruder bei XKEM an sich reissen wollen. wie genau weiss ich selber noch nicht ganz, aber irgendeine story muss am laufen sein. er hat geschrieben, dass er mich am laufenden halten wird. werde dann alles hier veröffentlichen!

Infos holt ihr euch am besten von hier:

http://investorshub.advfn.com/boards/board.aspx?board_id=281…

Ganz nach unten scrollen, da ist wie ne art Forum!

Grüssle und a guts Neus nachträglich,
Andi

Und nich vergessen: DURCHHALTEN!!!

[reitenhammer]

Antwort auf Beitrag Nr.: 36.327.315 von aamann am 07.01.09 20:06:38

danke schön für deine mühe

gruß hugo

[Helenium]

!

Dieser Beitrag wurde moderiert.

[mani40]

Antwort auf Beitrag Nr.: 36.377.858 von Helenium am 15.01.09 08:42:09

klingt gut, daß sich einige engagieren und Xechem vor dem Ausverkauf retten wollen.

Diese Vereinigung ist schon auf 27% gewachsen und hält angeblich 936 Millionen von 3,45 MIA shares. (Dachte immer die hätten 16 MIA ausgegeben?).

Jetzt suchen die wohl Geldgeber, die die Rettung unterstützen, damit sie sich, so wie ich das verstehe, einen Anwalt leisten können.


Jedenfalls symphatisieren meine 5 Mio Stücke mit Ihnen.

[reitenhammer]

Antwort auf Beitrag Nr.: 36.327.315 von aamann am 07.01.09 20:06:38

hallo andreas,

kannst du mir vielleicht einen kleine zwischenstand geben, denn mein englisch ist nicht sehr gut. das wäre nett wenn du oder jemand andres........

danke im voraus!

gruß hugo

[Helenium]

hallo miteinander,

da hier offensichtlich zensiert wird,... mein beitrag von neulich ist nicht mehr da...??!!, stelle ich den ganzen text nochmals hier rein. mal schauen was passiert.

behaltet eine steife oberlippe

Hi all,



This particular email is the first I’m sending to all the Xechem International shareholders that I have email addresses to. A smaller group of about 60 shareholders have been getting semi-regular email updates from me as to the “State of Xechem” (or something like that), over the last few months. I need to get in contact with everyone that I can now for a couple of reasons, mostly to discuss the current situation with Xechem’s Bankruptcy and our plans. As those of you that have communicated with me know, you’re always welcome to write me and ask questions about what’s going on, many times those questions turn into a group update. I have roughly 160 names on the list and what I’m concerned about is many of them not receiving the email, so if you can, please email me back if you get this so I can try to keep track of anyone that might have had issues receiving this. The problem is that I’ve had issues in the past with certain spam guard programs thinking that I’m a professional email marketing (translated into Spammer). I can’t even send an email to myself between two of my email accounts without the spam filter picking it up.



Anyway, here’s what’s going on:



1). For those of you that don’t know, we’ve retained Lane Hasler, a Chicago attorney, to represent us in the Xechem Bankruptcy process. His name is Lane Hasler and from what I can tell he’s pretty good. He’s got his own firm and has been doing corporate and bankruptcy work for something like 20 years. He fought pretty hard to stop the 5-HMF sale, which was approved by the court because the judge felt that if it wasn’t sold the company was going to lose it because of missed milestones. Currently we are working on a reorganizational plan that we are going to present to creditors committee and the court as an alternative to selling everything. I was originally on the Creditor’s Committee as Beverly Robbins representative, but resigned from the committee because of the work I’ve been doing with the shareholders. We felt that it would prevent me from doing certain things that I need to do because they needed me to sign a confidentiality agreement.



The most important thing I need to stress to the group is that attorney’s cost money. Many of the shareholders have already contributed to his fees since we requested $150 per person if it’s possible for you do so. We feel that that’s enough to fund our initial work, but we’ll probably need more from everyone later. If you’ve already contributed, thank you. If you haven’t, please do so. You can send a check to Lane, you can send money via wire transfer, you can PayPal it to me or I can accept a credit card payment through my merchant account with PayPal. I’d prefer that you send checks directly to Lane so that there’s nobody thinking that I’m trying to profit or anything, but I have no problem accepting the money and forwarding it to him.



Lane Hasler

1530 South State Street

Suite 17A

Chicago, IL 60605

312.893.0551



My PayPal account if you wish to send money that way is [e-mail]



I have wire information is you need it or if you want to use a credit card contact me and we’ll make arrangements.



We need to keep Lane paid so that he keeps doing the job for us, so please, if you haven’t sent something I highly encourage you to do so right away.



2). Our plan for reorganization – I want to give you a brief rundown of what we are planning, because very soon I’m going to need to get consent from everyone for that plan. If you have any comments, problems or if you approve what I’m going to outline, please let me know as soon as possible. I’ve attached our 12-point outline called “Xechem Invigoration Plan” which lists the key points that we need to work from, but obviously the plan needs to be much deeper than that. The most important points are management, financing and expansion of markets (or just increasing sales);



a). Management, our plan will include bringing Dr. Pandey back as the head of Xechem. Prior to the change Xechem was heading in a direction that most felt was going to take the company to the next level. I will work with the sales/marketing division to see what’s going on there and how we can move it forward. My background is 20 years in sales with sales management experience. There are others, but the most important one is Dr. Pandey.



b). Financing – we are working on financing and have a few people interested in working with us. Our hopes is that we’ll come up with $2 million in funding for working capital and to get started with the new plans. We’d also like to open it up to the shareholders, if you’re interested in helping out we’d like to talk to you. Chances are the funding will be via a straight promissory note, but there are other options we’ve tossed around.



c). Sales and Expansion of markets – Nigeria is obviously the first place that we need to focus, but there are other markets that we feel we can get into fairly quickly: India – there are as many or more people in India with sickle cell disease, one stat I’ve seen is that up to 12 million people in India might have SCD. Setting up a named patient program in India will at least start revenues coming in, the contact that the Pandey family have in India will help move the approval process along. The US – we need to get the work started back up for FDA approval, but in the meantime, we can be selling the drug through a compassionate release program. The European Union (EU) – there are as many in the EU with SCD as in the US and since Xechem has Orphan Drug Status there we’d have a quicker track to get approval. We’d also set up a named patient program in the EU so we can start bringing in revenue while working on approvals. African countries – I’ve had discussions with Charles Wambebe, the lead scientist on the NICOSAN™ project and he’s told me that wherever he goes in Africa he’s asked when they can get the drug in their country, with approval in Nigeria it’s believed that it will be much easier to get approvals in other African Countries, especially since the much of the work is already done and would just need to be customized for the other countries (such as the Drug Master File).



Other expansion projects would be to use the equipment Dr. Pandey had ordered to product and market HIV drugs in Nigeria and to look into bringing on a line of generic drugs. There is currently a push in Nigeria to stop importing many drugs, especially generics. If we start with one or two and build a line of products we are hopeful that the government will encouraged our efforts. On top of that there are a couple of other projects that we’ve been working on that we’ll be able to announce in the next month or so.



3). We are working on accurate accounting of where we stand as far as percentage of representation of the shareholders. If you’ve given me your share count and it’s changed up or down, please let me know. Right now our group of 164 shareholders represents 936 million shares out of 3.45 billion shares or 27%. On top of that we have a few other cards up our sleeves to push the percentage up, but we want to be very accurate. At some point, we might need you to verify those numbers for the court, so if you can find out how to get an accurate number by either pulling a report from your online brokerage account or asking them what you need, it would be helpful to us to have it taken care of before we need it. If you even want to just get it to us now, feel free to fax or email a copy of it to me, but that’s not necessary just yet. I know that’s a lot to ask, but understand something clearly, if we aren’t successful in what we are trying to do, your stock will be worthless, so we need all the help you can provide. The current plan that Xechem has is to sell Xechem Nigeria for $6 million and to try to start operations in the US based around Nicosan, which isn’t approved to be sold here. $6 million isn’t going to pay the creditors off, let alone the shareholders, so we need to pull out all the stops here to save your investments and we are. I can tell you that what I’m asking you for has a very significant purpose; it’s not that I want to pry into your personal portfolio. At some point we are going to have a list of shareholders that are going to have to be compared to numbers that the company has, so if you’ve given me wrong information because you bought or sold or estimated, I need that cleaned up. We also have no other way to verify your stock than with accurate reports.



OK, that’s it, there’s a lot more going on that I can’t talk about, but understand that we had a very good week last week and a lot of things started to fall into place. We need to stay focused though, so we have a number of things that we are working on and as mentioned, we need to make sure our attorney is paid or we aren’t going to get that work done. I’m not thrilled about writing you to ask for money, but I’ve also spent nine months working on this and I’m not interested in seeing it fall apart because we didn’t pay the lawyer.



I will update again in a day or two as there are a few things going on that I’ll want to keep you informed of. Again, please don’t hesitate to ask questions if you have any, I know there’s no place else to get information and I’m probably more up-to-speed with what’s going on than pretty much anyone you can ask.



Keep the faith folks, both the creditor’s committee and the Xechem Management are talking about what we are doing and we are solidly in the middle of what’s going on. We can’t promise anything yet, other than that we are doing everything we possibly can to save your investments, to save Xechem and to move this company forward. Right now all we can ask is for your full support and trust.



Thanks much,



Monty Forthun

732.887.8608

[Lapalie]

Greetings Xechemers from sunny Abuja...

Yes, you read correctly, I'm a currently sitting in Abuja, Nigeria, it's 2:02am (I only know it's night because I finally stopped sweating about an hour ago...).

I'm officially here representing GDPAU and have done the following in the 42 hours I've been here (including discussions about Xechem, just because there's a connection between GDPAU and Xechem):

1). Unless an extension is granted, Xechem loses the Nicosan license as of 11:59pm on January 31st. Why? Because they didn't pay the due royalties, they didn't file the proper reports and they ignored repeated letters asking for these things to be cleared up. Dr. Swift has been meeting with NIPRD and probably others to try to save it and is to the point that he wants a one-month extension. The decision will be made tomorrow and I'll know by 3pm what happens. We happen to have been spending most of the week with a new Nigerian Pharmaceutical company that might end up with the license, but that's just conjecture and hope, there could be a lot of other things going on behind the scenes. I know this because we've had meetings regarding number 5 below with two of the three people that will make the decision on the Nicosan agreement and they wanted to keep us informed. Xechem's board of directors has known this for a month, I knew it 3 weeks ago because I called NIPRD on another matter and promised the DG I would keep it to myself...

2). It was confirmed to us yesterday that Xechem had duty-free status for the equipment that was shipped in 2007.

3). We had a meeting with a Federal Agency that is working on an project that needs a consultant for the extraction and manufacturing process. By the end of the discussion I had a verbal committment to rent space in a certain unfinished building I've heard of at Sheda in Abuja. She also wants to collaborate with us to establish an Ayruvedic University in Abuja.

4). Today we were to go to a meeting with a Minister and his staff. When the meeting started we had nine Federal Government employees, five newspapers and a TV station covering the meeting. Might hit the papers tomorrow and maybe the news tonight, not sure though. Felt like an ambush until the praise and admiration from each member of the Federal employees started for a certain member of our group.

5). Next week we are signing a world-wide license agreement for a Diabetic drug made out of plants grown in Nigeria and discovered by a Nigerian Scientist. He has a US patent and I think patents in a few other countries. There will be many members of the press, many Federal employees, a few Ministers and a few DGs of Federal Agencies. It's being made into a pretty big deal we are finding out...

6). We met with the new DG of NAFDAC. He's very excited about the diabetic drug and hopes to work with us to get quick approval. He has also agreed to discuss the possibility of letting us take the lead in helping him establish a unified program for drug approvals in Africa. The proposal is to develop one set of standards and when a drug is approved in Ghana, it's approved everywhere in Africa, very similar to how they do it in the European Union. We are going to present the specs and then work through it with him.

7). I had a 30 minute discussion with three people who have given me very clear and detailed information on how pharma sales work here.

8). We've had 5 meetings in two days and well over 75% of the people we've met have immediate family that has sickle cell. The internal number in Nigeria with sickle is between 10 and 20 million. Nobody really knows because most don't go to hospitals, but they laughed at me when I asked about the 4-8 million figure we've used.

9). Nobody here can believe that Xechem can't sell Nicosan.

10). My next letter is to put an official proposal in front of the Xechem creditors committee because numbers 3 (contract drug extraction, manufacturing and possible sales license) and 5 (diabetic drug) will be licensed to Xechem if we are successful in getting our plan approved...

Oh, BTW, Dr. Swift is in town too, maybe we'll get together for lunch...

http://investorshub.advfn.com/boards/read_msg.aspx?message_i…

[falconara]

Antwort auf Beitrag Nr.: 36.480.482 von Lapalie am 30.01.09 11:49:42

..BITTE!!!

was bedeutet dies alles für UNS "Beschissene"???
mfG
falconara

[Helenium]

versteht irgendjemand die 56 mio von gestern?

[Lapalie]

Hier ein Artikel über Dr. Pandey:
http://allafrica.com/stories/200902040001.html

[aamann]

...und hier ein paar Fotos wie es da unten ausschaut - also die Bude steht noch













Der einzige weisse auf dem letzten Foto (mit Brille und Bart) ist unser Mann, der sich da unten für uns den Arsch aufreisst....

Grusss, Andi

[falconara]

Antwort auf Beitrag Nr.: 36.510.846 von Lapalie am 04.02.09 15:35:27

ein Mittel gegeg Diabetis
XECHEM ???

oder wird das hier nach dem selben "Strickmuster" ablaufen

>>>Geld zu machen und kein Medikament, das in großen Mengen verkauft werden soll ???????<<<

so, wie wir beschissen wurden
"könnten"
jetzt wieder Leute an der Nase vorgeführt werden

MUSTER: Nigeria-Conection

[aamann]

zwei habe ich noch:



und hier unten den Herr (links unten sitzend) den kennen wir doch auch (für mich eine auffallende Krawatte, für das, dass er Inder ist *ggg*)

[aamann]

...hier werden die Kräuter geliefert...



Lagerpunkt:





in den Schlagzeilen ist Dr. Pandey auch bereits:



Diese Bilder stammen übrigens von Monty (Mann mit Bart und Brille) und wurden in den letzten Tagen in Abuja und Umgebung aufgenommen.

Gruss, Andi

[aamann]

Antwort auf Beitrag Nr.: 36.512.718 von falconara am 04.02.09 18:09:58

falconara, ich glaube uns würde es schon reichen wenn das ding wieder auf über € 0.1 raufschiesst - ist ja noch nicht lange her...

war jetzt ein Wunschtraum!!

[falconara]

Antwort auf Beitrag Nr.: 36.512.904 von aamann am 04.02.09 18:27:45

"Spass-Antwort":
< träum' weiter >

sollten Deine Träume mal wahr werden, würde "es" mir besser gehen
mfG
falconara

[physik]

Antwort auf Beitrag Nr.: 36.512.818 von aamann am 04.02.09 18:18:27

Dieser 'Monty' (LaMonte Forthun) ist eine ganz wichtige Person in dem Projekt. Er wirft sich voll hinter eine Aufklärung des Falles.

Berücksichtigen muß man, daß er dem Team von Pandey sehr nahe steht. Pandey, wir erinnern uns, war Zielscheibe für sehr viel Kritik als er noch Xechem leitete. Es wurden große Kredite aufgenommen, er und einige seiner Familienmitglieder bekamen großzügige Gehälter und mit Xechem ging es nicht voran. Dann übernahm diese nun stark kritisierte Gruppe um Dr. Swift.

Wer hier die guten und die bösen sind, ist von außen nicht zu klären. Aber auch unter Swift ging es nicht voran.
Bedenken sollte man, daß das Arbeiten in Nigeria nicht immer unseren Vorstellungen von üblichem Geschäftsgebaren entspricht...

Die Quelle Investorhub, ist ebenfalls kritisch zu bewerten. Ich erinnere daran, wie stark dort zensiert wurde. Meine eigenen, damals Pandey-kritischen, Beiträge wurden schnell gelöscht und ich wurde gesperrt (von einem User 'drifter', der oft die Seite wechselte).

Nun wird in dem Thread verkündet, daß die Insolvenzanwälte aus dem Thread zitieren - es wird dort also vorsichtiger geschrieben werden - und zielgerichteter.

Pandey gründet gerade eine Aryuvedische University in New Jersey. Wenn ich das richtig verstanden habe, in den Gebäuden, in denen Xechem residierte. Die Uni benennt er nach sich selbst. Ein Zug, der mich stutzig macht.
Und er kommt mit einem neuen Wundermittel. Ein Kräuterextrakt zur *Heilung* von Diabetes. Als ein kritischer Artikel eingestellt wurde (aus demselben Journal, in dem auch das Wundermittel verkündet wurde), wurde dieser stark angegriffen.
Objektiv geht da nichts zu. Das Board ist voll mit Gläubigen. Zum Teil im wahrsten Sinne des Wortes. Autoren, die meinen, Gott persönlich stünde hinter ihrem Investment. Ich finde diese Einbindung blasphemisch, auch wenn man vorgibt, an die Hilfsbedürftigen zu denken.

Doch nun zu einem interessanten Beitrag aus i-Hub

Posted by: B Lane Hasler Date: Thursday, February 05, 2009 5:05:36 PM
In reply to: None Post # of 193392 [Send a link via email]
General Bankruptcy Update

Hearings were held today in the Xechem bankruptcy case.

An order was entered which sets out procedures that prospective bidders for the stock in Xechem Nigeria must follow in order to have access to documents and to have access to inspect the facility. It was demonstrated in open Court that LaMonte Forthun has complied with such procedures and is now entitled to conduct due diligence in Nigeria.

An order was also entered which grants LaMonte Forthun discovery of Xechem documents, including financial records.

No further hearings are scheduled at this time.

Copies of all records in the bankruptcy case are available through the Electronics Case Filing System - visit the Courts website at www.ilnb.uscourts.gov for further information.

Regards,

B. Lane Hasler

[physik]

Antwort auf Beitrag Nr.: 36.528.192 von physik am 06.02.09 15:17:54

Ich lese heraus, daß 'unser Monty' als potentieller Käufer von Xechem auftritt.
Das wird spannend.

[physik]

Antwort auf Beitrag Nr.: 36.528.192 von physik am 06.02.09 15:17:54

und Monty wird gerade richtig sauer, weil er gelesen hat, daß einer der Insolvenzanwälte bei iHub liest:
"Why do I feel like I just got sent to the principal's office?

My question for Mr. Draper is, instead of spending time on iHub, maybe you should make a couple of phone calls to the employees of Xechem Nigeria who haven't been paid for two months. Ask them why they haven't had any power in their office for nearly a month and why there's no production. Ask them why there's no product available. Maybe you should contact the MD of Xechem Nigeria and ask him why he threatened us with calling the local police when we showed up to look at the facility on a tour that was suppose to have been arranged by Bank PHB. Ask the MD where the money Bank PHB loaned Xechem recently to clear over $6 million in equipment from customs went. Ask him why he only shows up to work one day a week on a good week, when most weeks he doesn't show up at all.

Or better yet, just give Dr. Swift a call and ask him how he can leave the country when all of the above problems are not resolved.

Please, feel free to use this in court because I'll get you a stack of sworn affidavits to everything I'm saying. You see Mr. Draper, I, unlike your clients, can back up what I say with facts, I don't just throw things out and hope nobody cares enough to check into it. "

[falconara]

Antwort auf Beitrag Nr.: 36.528.270 von physik am 06.02.09 15:24:47

Hallo >physik< !!!
servus, schön daß es DICH auch noch gibt.
Es freut mich wieder etwas von Dir zu lesen!!!

mfG
falconara

[aamann]

Antwort auf Beitrag Nr.: 36.528.192 von physik am 06.02.09 15:17:54

Hallo physik, hallo Xechemer !

Schön, dass es dich auch noch gibt, an di hob i jo scho gornimma glabbt!

Alte Kämpfer sterben halt nie aus, Gsd...

Dass da unten sicher etwas spannendes abläuft, da gib ich dir recht. Habe zwar wenig Zeit zu recherchieren, aber ich glaube ich muss mir langsam die Zeit nehmen. Im I-Hub geistert ein Link zu einem Video (von CNN!!!! gemacht) herum. Macht euch am besten selbst ein Bild:

http://edition.cnn.com/2009/WORLD/africa/02/06/nigeria.medic…

Weiters setzt Monty, unser Mann (mit Brille und Bart ) laufend Mails ins I-Hub wie es ihm da unten läuft. Mein Eindruck: der ist Pandeys Schatten (oder besser gesagt spendet er Pandey Schatten:laugh. Monty hat fast überall seine Finger im Spiel!

Ich überlass euch noch neue Bilder von Monty:









Es grüsst und wünscht euch ein schönes WE,

Andi

[physik]

Guten Abend zusammen.
Ja, bei einer so spannenden Geschichte will man doch dabei sein.
Im iHub kam dieser bewegende Bericht von Monty (sagt mal, früher war der aktivste Kerl im Board drüben doch bigdaddy. Monty ist auch ein ziemlicher bigdaddy - isser das?)

"Good morning everyone...

First of all, understand clearly that the lack of comment on the current situation is in no way indicative of my attitude or emotions about it. It's more trying to keep a certain level of restraint and professionalism than being worried about Xechem's attorney's taking something that I type here and using it against me.

With that said, I'm going to tell you what happened yesterday, I tried writing this in a brief statement, but as you can see, I failed miserably at being brief. I sit here with a lot of emotion about the situation, I feel badly for Dr. Pandey, but as he likes to say, we shouldn't feel badly for him, we should feel badly for those that are being denied access to Nicosan because of this. I've met some of those people, I've met parents of children on Nicosan and I know some that know the situation at Xechem and are scared that their medicine might not be available.

So, I type this with a heavy heart as the last 24 hours have been very difficult to live through because of the actions of a few people who have proven that they we go to any extreme to protect themselves.

Lane was able to successfully get a court order allowing any bidder access to the Nigerian facility and access to company records. This happened on Thursday. The order said that as of 10am Lagos time, the records would be available at Bank PHB in Lagos and that if any bidder wished to inspect the Xechem facility in Abuja they should arrange it with a specific person at Bank PHB. Friday morning I contact that person, who had no idea what I was talking about. We made arrangements after a few meetings to go out to Sheda because Dr. Pandey wanted to visit some old friends in the building next door (Advanced Labs). On the way I got in touch with the bank contact again who said he had gotten an email from Dr. Swift with the court order and approval and to work with us. The bank contact had to get in touch with Ireti Oniyide to set it up. I told him we were already on the way (I had emailed earlier with the court order attached and a time we hoped to get in). At the same time, I sent a text message to an employee of Xechem to see if Ireti was there and was told that he had just left and had instructed the guards to not let us in.

When we got there, we were expecting the guards at the main entrance to turn us away, but I think that because Dr. Pandey said we were going to the Advanced Labs building, not Xechem, they let us through. We went to the other building, met a bunch of old friends of Dr. Pandey's, walked about to see the new buildings that have been built for another company and then got ready to leave. I say got ready to leave because the other guy with us had already tried to get in but found that the security guards had been instructed to not let us in. As we were ready to drive away Dr. Pandey decided he wanted to see for himself, so we drove up front. He was on the left side of the car and got out right away, I was on the right and needed to unbuckle and get me feet untangled from the strap of my bag, so he was already down the steps infront of the building before I even got out of the car. What I saw was Dr. Pandey walking down and an security guard armed with a machine gun (they are common here, but it's no less upsetting to see) walk out of Xechem's reception area and meet him in front of the building. I couldn't hear them, but as I walked down I heard the guy say that there's no one available to see him and that he couldn't let him in.

I want you to get this visual, I really wish I had grabbed my camera because it would have been one of those never forgotten pictures...

70 year-old founder of the company, standing on the front steps of the complex he helped created, being denied access to the building by a 20 year-old military-looking man carrying a machine gun.

We bearly said a word to each other on the ride to the hotel, which is an hour plus. Finally, when I decided it was time to move on, all he could say was, "I can't believe it."

There's been a lot of communications about the incident with Xechem's attorneys and it's actually starting to get comical, including a series of allegations that they are starting to bring on me personally and are continuing to bring on Dr. Pandey.

I just want to say this, on the record, to Robert Swift, Steve Burg and the Xechem legal team. I have no reputation to protect, I have no possessions you can take, I have no money to run out of, I don't care what you say about me or what I'm doing, so understand very clearly that you can't intimidate me with a machine gun, you can't threaten me with court orders to turn over emails and you can forget about me getting tired of this and walking away. I'm not going anywhere and if it's the last thing I do on this planet, I will see that each and every one of you will answer for your actions. In the last 24 hours you've crossed a line that you can't return from and I am making it my mission in life to see to it that you are exposed for what you've done and are doing. Keep one thing in mind, when you tell the truth it's easy to tell your side of a story multiple times. When you make things up, it's hard to remember what you said from day to day. We can repeat our story and side of events in many situations as many times as we need to and can get people to back us up, can you say the same?

Dr. Swift, it must be difficult for you to come to a country half-way around the world and have so many people love the man that you've tried to destroy. It must have been tough for you to sit in your hotel room last Tuesday night as see the Nigerian Television Network's story on Dr. Pandey signing the license agreement for a diabete drug and to hear so many people thanking him for what he's done for Nigeria. It must have been difficult for you to drive around and see so many copies of "This Day" being sold on the street with the main headline of the paper being about the Diabetes Drug signing. You have no idea how disappointed people in Nigeria are that you are running Xechem and for what you've done to Dr. Pandey, but the only way you can justify what you've done is to try to tear his reputation down. Unfortunately, fewer and fewer people are listening to your lies and more and more are realizing what you've done. They are sad for Nicosan, Xechem and Dr. Pandey, yet they are excited about his return and the potential for the new drug. Even the employees at Xechem Nigeria are sad that Dr. Pandey wasn't allowed in. Ireti has taken the Internet away from them so they don't communicate with the outside world, next he will need to remove cell phones because both times I've been there I received text messages from employees telling me that our presense offered them hope for a new future (yes, I have contact with a few of your employees). Your employees are hoping for a new future Dr. Swift, what does that tell you? Maybe all they hope for is not having to work in the dark, without A/C in the 100+ degree heat, or maybe all they care about is getting paid for December and January's salaries (minor detail in their lives I'm sure). I find it hard to believe that you left Nigeria without resolving the issue of power and salaries and the equipment in Lagos (yet again). But I guess when you don't care about anyone but yourself, it makes perfect sense.

I find it amazing that people still blame Dr. Pandey for Xechem's problems because he hired Ireti in the first place, yet Dr. Swift has been managing Xechem for 19 months and has allowed the man to run the place into the ground.

They don't want us in the building because they know what we will find. What they don't realize is that no fewer than 10 people have already told us what we will find and they have all told us that exact same thing. I was sceptical when I heard it from the first couple of people, but when three employees of SHESTCO told us the same things, it was pretty clear.

Xechem shareholders, we need to stick together in this fight and be persistent in our goals. We need do what we can to remove current management and the current board of directors of both Xechem International and Xechem Nigeria and replace them with an entirely new set of management and BOD. There are no options. If we let up, the plan that has been put in place by these guys will come together and they will walk away with more than just 5-HMF. We have an option to fight or let it happen and I'm hoping that you will all, and I stress all, stick with us for the long-haul. I also appeal to the creditors to understand that what you've been told about what happened in early 2007 is not what it seems. You feel that fraud was committed and yet nobody has offered up any solid proof of that, nor have they felt strongly enough about it to start a criminal investigation. If millions were stolen, why hasn't there been arrests? Why hasn't proof been presented? Why is everyone accepting what was said as fact without looking into it? Why can you just take it for fact that equipment was sent to India, yet when you ask them about it they change their story? Why haven't you asked current management for a complete list of where the bond money went, they have all the bank records. I have been granted discovery of these records and will be plowing through a storage facility full of records as soon as I get back, I hope some will offer to help me so that the process doesn't take as long and we can find some answers fairly quickly to answer your questions. Why is the guy that yelled the loudest was the one that was listened to? OK, that one I can answer, because the other guy was too proud to dignify the BS with an answer. Well, I'm here now and I'm yelling louder and I've got proof that stories have been changed and that things didn't happen as they said they did and that we can save your investments. So you admit you made a mistake and you want to give Dr. Pandey an opportunity to make things right, what's that hurt you, your pride? You're willing to throw away thousands of dollars or hundreds of thousands of dollars to protect your pride? Put yourself in his shoes for a minute and see what he's had to deal with and how he's dealt with it. He's been called a thief and he's been told that he'd be arrested if he came to Nigeria. Instead of hiding, he's out rebuilding his lab and his life to be better than ever. He went to Xechem and was denied access by an armed guard, does that sound like a guy that thinks he did something wrong? Contrast that with Mr. Oniyide, who left the complex when he heard we were coming and instructed his guard to not let us in, in direct violation of a court order that he was fully aware of.

Are you sure you're on the right side of the fence. Or as one of the key players has said to me numerous times, "You're backing the wrong horse..."

At the end of the day we know that we can sleep with a clear conscience, unfortunately, there is so much work to be done we don't get much sleep, but at least that's a decision that we can make for ourselves, not one that is made for us..."

[OttomanRosen]

Ebenfalls von Monty

Monday, February 09, 2009 8:14:22 PM

We had a great day today so I thought I'd share a bit of it with you all. This morning Dr. Pandey was to meet the Minister of Information and Communications Prof. Dora Akunylli at what we thought was a press conference. She wanted to highlight Dr. Pandey's contribution to Nigeria by talking about his involvement in bringing Nicosan to the market. So we get to the place it's being held and it turns out that she was holding a huge event to announce her project to rebrand Nigeria. Every Ambassador to Nigeria was there and an auditorium full of guests. They brought us to the front row (which meant that we were on the news tonight, not really excited about that...). During the Minister's speech she talked about Dr. Pandey a couple of times, but after the public contribution/question section of the program they asked Dr. Pandey to come up and speak about Nicosan and the new Diabetes Drug he just licensed. Later, the Minister asked us to a meeting in her office to see how we can help her and how she can help us. It was a great meeting that ended with some very exciting news...

Another important meeting tomorrow...

[steini69]

Antwort auf Beitrag Nr.: 36.548.245 von OttomanRosen am 10.02.09 12:56:19

Spannender als jeder Krimi ...

Wenn das gut ausgeht schreibt monty Börsengeschichte !!!

Steini hofft mit seinen restlichen Xechem Anteilen natürlich auch auf selbiges.

[physik]

Antwort auf Beitrag Nr.: 36.561.673 von steini69 am 11.02.09 22:14:48

Allem Anschein nach ist Monty ein Beschäftigter von Pandey. Ein guter Typ, aber ob die Lösung, Xechem an Pandey zurück zu übertragen so schlau ist?
Monty sammelt Geld für eine Anwalt der Aktionäre ... Montys Reisetätigkeit für die Sache wird augenscheinlich von Pandey bezahlt. Warum bezahlt der nicht den Anwalt?

Pandeys Umgang mit Xechem war - das darf man nicht vergessen - eine Katastrophe!
Er hatte damals mehrere Familienmitglieder und sich zu sehr hohen Jahresgehältern bei Xechem unter Vertrag, hat wiederholt Aktien ausgegeben, Sonderkonditionen für Geldgeber geschaffen, die den Kurs in den Keller prügelten. Und er hat nicht eine Packung Nicosan verkaufen lassen. Das Gebäude wurde nicht weitergebaut. Sein Public Relations Guy (Steve Burg) hat keinerlei Public Relations Anstrengungen unternommen. Und arbeitet jetzt bei 'den anderen'. Die Wirksamkeit von Nicosan wurde meiner Erinnerung nach in einer einzigen Studie an wenigen Probanden studiert.
Ich erinnere mich an Fotos eines NMR-Spektrometers der Firma Oxford, das irgendwo in den furchtbar rümpeligen Räumen von Xechem Nigeria herumstand und nach Nigeria verschifft werden sollte. Zum Betreiben des Gerätes braucht man flüssiges Helium. Ich möchte wetten, daß man dies in Nigeria nahezu nicht bekommt.
Die anderen Nicosan-Anlagen, die man damals auf den Fotos aus New Jersey sah, waren schrottige Maschinen zum Trocknen, backen, pressen.

Kurz: man darf auch heute Xechem und das Produkt nicht überbewerten. Pandey ist für mich keine seriöse Persönlichkeit. Seine Eitelkeit ist fast schon sprichwörtlich.

Nun kämpfen die Aktionäre dafür, Xechem vor dem Bankrott zu bewahren - Pandey und seine Mannen werden es zurückkaufen. Das ist sicher ein guter erster Schritt. Aber dann? Ich traue Pandey nicht so ganz über den Weg.

Aber spannend ist es allemal :-)

Was meint Monty mit seinem kryptischen letzten Posting? Was passiert bei Xechem, so daß man sich beeilen muß? (ich nehme mal an, die Maschinen werden demontiert und abtransportiert)

"We are currently working on the plan to be submitted to the creditors committee for review. Lane can answer the question of time line better though. I will say that it's critical that we get things done because of what we are hearing from very credible sources about what's going on out at Xechem Nigeria. Not only are they credible, but it is from multiple sources with the same information. When you hear something from an employee you wonder if they have an axe to grind. When you hear the same thing from someone outside the organization you start to give the information credibility. When you hear the same thing from five different sources, including the people who work in the building next door, you know it's fact. "

[physik]

Antwort auf Beitrag Nr.: 36.563.171 von physik am 12.02.09 09:38:30

"Räumen von Xechem Nigeria " soll natürlich heißen "in den Räumen von Xechem, New Jersey"

[aamann]

Hi guys,
es freut mich, dass sich das Forum so langsam wieder mit der alten Garde füllt!

[EKKI1997]

Antwort auf Beitrag Nr.: 36.564.710 von aamann am 12.02.09 12:46:17

wir waren doch nie weg

[EKKI1997]

Antwort auf Beitrag Nr.: 36.564.767 von EKKI1997 am 12.02.09 12:55:12

gibt es nichts neues?
würde mich über ein paar infos freuen.

grüße
ekki

[Lapalie]

Antwort auf Beitrag Nr.: 36.667.793 von EKKI1997 am 27.02.09 15:05:24

Hier was Neues aus dem IHUB:

Posted by: lmf1264 Date: Friday, February 27, 2009 10:56:19 PM
In reply to: None Post # of 193786 [Send a link via email]
Here are a few interesting documents...

http://xkem.info/NJStateTax.pdf

http://xkem.info/IRS.pdf

http://xkem.info/XechemIntJanFinancial.pdf

The first shows that they never filed any 2008 NJ Gross Income Tax - Employer Withholding reports.

The second shows that they never filed any 2008 Federal Withholding-FICA reports

The third is the most interesting... It shows what money came in and went out in January for Xechem, have a look, I think you'll find it very interesting.


http://xkem.info/NJStateTax.pdf
http://xkem.info/IRS.pdf
http://xkem.info/XechemIntJanFinancial.pdf

[reitenhammer]

Antwort auf Beitrag Nr.: 36.673.062 von Lapalie am 28.02.09 11:43:00

hallo alle zusammen,

gibt es neue nachrichten von xechem.

gruß

[Egobuster]

hmm.. anscheinend nicht so... ich verstehe aber irgendwie nicht wie diese 100% kursschwankungen immer zustande kommen... und vor allem ist doch das volumen immer recht gewaltig für so eine "firma", oder was meint ihr?

lg ego

[physik]

aus ihub (von lmf):
"Here's what I know...

Yes, the license was revoked by NIPRD on Friday and it's been confirmed through a very reliable source. Xechem claims it's invalid, but unfortunately before Xechem's attorney called the courtroom he failed to read the letter which clearly stated the clauses as to why the license was revoked. He also didn't know what NIPRD stood for, so I guess we shouldn't be surprised that he didn't read the letter. They are planning on fighting it. Let's see, Xechem - no money; NIPRD - Nigerian Federal Government program backed by the Ministry of Health. Yet another example of a really bad decision...

FYI, it doesn't help your case if you haven't turned in your reports or payments. But here's what I want to know...

1). On January 31st the license could have been revoked.
2). Xechem was given extra time to "get their affairs in order" as I like to put it. In other words turn in the reports and pay the royalties.
3). On February 13th or 15th (I don't remember exactly), the second deadline was given to only turn in reports. If it happened, Xechem's attorney isn't aware of it and has no confirmation (as was stated in court today).
4). It was confirmed on Friday, March 13th that not one Kobo was paid to NIPRD.
5). Dr. Swift and Steve Burg paid themselves over $100,000 for consulting fees and travel expenses in January, when they were given the opportunity to save the license agreement...

As for the facility, you all saw the letter from the employee (Voice Of Xechem), where they said that they got paid on March 6th and 7th. We've also recently heard that power was turned back on roughly the same time. I don't have any information on production though, what we had heard from one of the production people is that they would be able to produce the API, but then they couldn't do anything with it because they didn't have packaging materials.

The bottom line though is that NIPRD has pulled the license, so power, production, employees, paper towels in the rest room, none of it matters. Xechem became a one product company and now that product is gone.

It was discussed in court today though that the "plan" that Xechem has going forward officially is to get funding to develop a derivative of Nicosan and to get it into Clincal Trials as soon as possible. So, there you have it, from the management team that had Nicosan and 5-HMF and didn't do anything, they now have put up plans to develop a new version if the drug they just lost.

Yes, we are working on this from our perspective, in fact we've had many meetings regarding this over the last month (contingency plans). In the 14 days we were in Nigeria, Dr. Pandey and all the people we met with came up with four plans for the facility if Nicosan should be lost. Some are long-term, some are shorter term, but all are doable.

One of my ideas was to put a basketball court and batting cages in the large building at SHESTCO, unfortunately, I got outvoted...
"

[reitenhammer]

Antwort auf Beitrag Nr.: 36.780.605 von physik am 17.03.09 09:40:01

was heißt das jetzt, ist alles vorbei

[Lapalie]

8k out...

8-K 1 xechem_8-k.htm XECHEM INTERNATIONAL, INC. 8-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934

Date of Report: March 2, 2009
(Date of earliest event reported)


XECHEM INTERNATIONAL, INC.
(Exact name of registrant as specified in the charter)

Delaware

0-23788

22-3284403
(State or other jurisdiction of incorporation)

(Commission File No.)

(IRS Employer Identification No.)


Xechem International, Inc.
PO Box 327
Middletown, NJ 07748-0327
[phone]
Registrant’s telephone number including area code)

NOT APPLICABLE
(Former name or former address, if changed since last report)




Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



1


Item 5.02 Resignation of Director.

Resignation of Martin Biggs from Board of Directors. Effective May 17, 2007 Dr. Martin Biggs was added to the Board of Directors of the Company by approval of a majority of the existing members of the Board of Directors, as the second of the nominees on behalf of the purchasers of Units comprised of Convertible Debentures plus Warrants pursuant to the Securities Purchase Agreement of the Company dated as of April 4, 2007. On March 2, 2009, Dr. Biggs resigned from the board and any further affiliation with the Company citing personal commitments that would no longer permit time to devote to Xechem.

Item 8.01 Other Events.

On November 10, 2008, Xechem International, Inc. (the "Company" or "Xechem") and one of its subsidiaries, Xechem Inc., filed voluntary petitions for relief under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Northern District of Illinois (the "Bankruptcy Court") to suspend all litigation and to restructure its debt. A copy of the press release issued on that date announcing the bankruptcy filing is attached.

Demand Letter from the Creditor Committee. The Company received a letter dated March 10, 2009 from Charles Ganz, Vice-Chair of the Official Committee of unsecured Creditors of Xechem International, Inc. and Xechem, Inc. advising that there are several causes of action that may exist which should be preserved for the benefit of the applicable estate, including against all applicable persons, entities and insurance coverage. A portion of what the letter includes as to the following allegations: The letter has made allegations of fraud, breach of fiduciary duty and inadequate disclosure, among other things.

The Company received letters from two holders of convertible debentures. The first was from counsel to an institutional investor and additional investors with regard to a Stock Purchase Agreement dated April 4, 2007 (the “SPA”) for the purchase price of $4,959,663. The letter was addressed specifically to Dr. Pandey. They claim misrepresentations and omissions of material fact in connection with their investment and that they are commencing an action against Dr. Pandey.

The second letter was received from an individual investor on behalf of himself and all similarly situated holders of the Secured Convertible Debentures Due April 4, 2008, placing a demand for repayment of the Debentures plus interest and lost profits resulting from his investment and are seeking redress against Ramesh C Pandey and all who participated in alleged negligence, misrepresentations and breaches of fiduciary duty.

Item 9.01 Exhibits.

Form of press release dated November 10, 2008 announcing bankruptcy filing of Xechem International, Inc.

Exhibit No.

Description
99.1

Press Release dated November 10, 2008


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Xechem International, Inc.

Dated: March 17, 2009

By:
/s/ Robert Swift
Chief Oversight Officer

[falconara]

Antwort auf Beitrag Nr.: 36.780.605 von physik am 17.03.09 09:40:01

na dann, wieder mal endgültig in die schwarze Sch.... gelangt!
Gratulation falconara für in den "Sand gesetzten €uronen!
und tschüß

[falconara]

Antwort auf Beitrag Nr.: 36.788.500 von falconara am 18.03.09 01:43:29

für die in den "Sand gesetzten €uronen!

[p0_2011]

wann gehts endlich los :-)
mag sand am strand

[Helenium]

May 08, 2009 8:19 AM ETXechem International Inc.
SnapshotPeople Company Overview
Xechem International, Inc., a biopharmaceutical company, engages in the research, development, and production of generic and proprietary drugs from natural sources. Its principal product under development is NICOSAN/HEMOXIN, which would be used for the treatment of sickle cell disease. The company also applies its proprietary extraction, isolation, and purification technology to the production and manufacture of Paclitaxel, which is an anti-cancer compound used for the treatment of ovarian, breast, small cell lung cancers, and AIDS-related kaposi sarcomas. In addition, Xechem International engages in the research and development of other compounds using traditional medicinal plants, microbia...

Xechem International, Inc., a biopharmaceutical company, engages in the research, development, and production of generic and proprietary drugs from natural sources. Its principal product under development is NICOSAN/HEMOXIN, which would be used for the treatment of sickle cell disease. The company also applies its proprietary extraction, isolation, and purification technology to the production and manufacture of Paclitaxel, which is an anti-cancer compound used for the treatment of ovarian, breast, small cell lung cancers, and AIDS-related kaposi sarcomas. In addition, Xechem International engages in the research and development of other compounds using traditional medicinal plants, microbial fermentation, or semisynthesis to produce anti-cancer, anti-fungal, anti-viral, anti-inflammatory, anti-aging, and memory-enhancing compounds. Further, the company also focuses on phytopharmaceuticals and other proprietary technologies for orphan diseases. It operates in the United States, India, the People's Republic of China, and Nigeria. The company was founded in 1994 and is headquartered in New Brunswick, New Jersey. On November 9, 2008, Xechem International, Inc. filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the Northern District of Illinois.

Hide Detailed Description
100 Jersey Avenue

Building B Suite 310

New Brunswick, NJ 08901

United States

Founded in 1994

80 Employees
Phone:
732-247-3300


Fax:
732-247-4090


www.xechem.com
Key Executives
Xechem International Inc. does not have any Key Executives recorded. If you would like to update data for this company, follow the link below and fill out the form.

Submit Company Information

von heute, nur was soll das??
es gibt nochmals eine neue info (ca. 15 seiten die kosten 20 $) Stand 07.05.2009
hat jemand news?

[Strandlaeufer1]

Seltsam, seltsam, irgendwas passiert hier

[Helenium]

Antwort auf Beitrag Nr.: 37.234.986 von Strandlaeufer1 am 22.05.09 17:18:50

hallo , auch noch so ein stiller mitleser...

wenn man sich den 5 tages chart anschaut wurde fast nur gekauft...

[Strandlaeufer1]

Antwort auf Beitrag Nr.: 37.235.263 von Helenium am 22.05.09 17:50:15

Hallo
ja, hab ich auch beobachtet.
Und das mit relativ hohen Stückzahlen (gestern 80 Mio)
Sieht so aus, als ob sich jemand unauffällig
eindecken will.
Fragt sich nur, was dahintersteckt.
Ich denk, die haben Capter 11 ????

[Helenium]

Nigeria: Country Takes Over Sickle Cell Drug
Adole Hassan
27 March 2009

--------------------------------------------------------------------------------
Email|Print|Comment
Share:
Abuja — The Nigerian government will manufacture an indigenous remedy for sickle cell anaemia following the collapse of attempts to produce it commercially by the Nigerian subsidiary of a US-based pharmaceutical company.

Niprisan - marketed as Nicosan by Xechem International, the company that till recently held the licence to produce it - is taken by thousands of Nigerian sickle cell sufferers to alleviate their symptoms. Production slowed down in the last year and sources say it has now ceased completely.

But the government's National Institute for Pharmaceutical Research and Development (NIPRD), which originally developed the treatment, told SciDev.Net last week (19 March) that it is taking over production of Niprisan.

"We wish to confirm that the exclusive licence given to Xechem International for the manufacture and marketing of Nicosan has been withdrawn and the agreement in this regard terminated," said Niyi Ojuolape, special assistant (communication) to the Nigerian Minister of Health.

"In the mean time, NIPRD will be producing the drug to make up for any possible shortfall that might arise before a new licensee is appointed," Niyi told SciDev.Net in an email.

Niprisan is based on extracts from West African plants that had been known to generations of a Nigerian family as an effective treatment for sickle cell anaemia. Around 12 million people worldwide suffer from the painful genetic illness.

The family who owned the recipe initially made a pioneering agreement with NIPRD, widely cited as a case study in "benefit sharing" - allowing local groups to have a stake in the profits from commercialising indigenous products.

The licence to produce the drug was subsequently bought by Xechem International, which held it for six years - during the last few of which it was dogged by allegations of fraud and mismanagement.

In November 2008 Xechem International filed for bankruptcy protection in the United States (see Bankruptcy leaves indigenous sickle cell treatment in jeopardy).

Charles Wambebe, chief executive officer of the International Biomedical Research Institute in Abuja, Nigeria, and former director-general of NIPRD, says: "The development is a good one for the country. Now sickle cell sufferers in Nigeria can access the drug cheaply".

"Seeing that Xechem failed to live up to their expectations, let the status quo remain - that is, NIPRD producing the drug for Nigerians. After all Xechem did not add any value to the whole process," he told SciDev.Net.

But NIPRD has said that its own production of Niprisan will be temporary, pending the appointment of a new licence-holder.

Relevant Links
West Africa
Nigeria
Health
LaMonte Forthun, a Xechem shareholder who is attempting to resurrect the firm under different management, says that it was important in the longer term to find a company to take over production of Niprisan.

"The people at NIPRD are all top notch and they have an emotional attachment to the product which is something that is really needed right now," he says.

"It's hoped that they don't let this experience ruin future relationships or collaborations with public companies.

"NIPRD is a research and development group and they are second to none, but having to deal with marketing, sales, distribution, commercial scale quantities of raw material acquisition, etc., would distract them from what they specialise in - developing new drugs."

Be the first to Write a Comment!

Copyright © 2009 SciDev.Net. All rights reserved. Distributed by AllAfrica Global Media (allAfrica.com). To contact the copyright holder directly for corrections — or for permission to republish or make other authorized use of this material, click here.

AllAfrica aggregates and indexes content from over 125 African news organizations, plus more than 200 other sources, who are responsible for their own reporting and views. Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica.


Offensichtlich wird nicosan jetzt von nirp produziert

[Helenium]

Antwort auf Beitrag Nr.: 37.235.353 von Strandlaeufer1 am 22.05.09 18:02:24

es gab ja überhaupt keine informationen mehr,

monty hat nicht mal mehr auf e-mails geantwortet, am amfang ging das innerhalb kürzester zeit...
monty wird in dem text auch erwähnt...
vielleicht gibt es einen weg aus chapter 11 wieder rauszukommen oder die haben ein anderes mittel mit dem es jetzt losgehen könnte...
spekulationen über spekulationen...

aber schön dass da noch immer ein paar still am mitlesen sind...

vielleicht haben wir ja ein kleines stück glück...

[Strandlaeufer1]

Antwort auf Beitrag Nr.: 37.235.628 von Helenium am 22.05.09 18:35:25

monty wird in dem text auch erwähnt...

Ja, hab ich gelesen.
Ist mir aber absolut nicht klar, was der für eine Rolle
in diesem Wirrwarr spielt

[Strandlaeufer1]

Jetzt bin ich aber mal gespannt, ob das Ding nicht wieder
wie ne Seifenblase implodiert ?!

[Helenium]

Antwort auf Beitrag Nr.: 37.235.685 von Strandlaeufer1 am 22.05.09 18:42:35

ich versteh auch nicht, wenn nicosan jetzt von niprd produziert wird, warum dann hier der kurs steigt...

vielleicht sind ja wieder die jungs von shakerzz oder wie der hieß wieder unterwegs...


völlig undurchsichtig...

[Helenium]

ich hab noch irgendwo eine nachricht anscheinend vom 20.05.2009 gefunden...
die wollen dafür aber 600,00$...
keine ahnung was das für news sein könnten...

an alle stillen mitleser ich hoffe das eswieder etwas up geht und vielleicht doch erfreulichere nachrichten kommen


bis dann

[physik]

Monty, LaMOnte Forthun, arbeitet mit Pandey und der GDOAU zusammen, Kreditoren von einem Rettungsplan für Xechem zu überzeugen, das anscheinend korrupte Führungsteam abzulösen und die Lizens für Nicosan zurückzubekommen.
Alles nicht ganz unwahrscheinlich...

Und für einen Zock ist es immer gut - kann man die Aktie denn in D inzwischen wieder handeln?

[falconara]

Antwort auf Beitrag Nr.: 37.240.878 von physik am 24.05.09 14:23:43

HALLO GROSSER MEISTER!!!

Handel in D?
Kaum, bei dem Marktwert von 000000000005 USD

ich hab' den gesamten Schrott noch "im Keller liegen"
servus
falconara

[physik]

Antwort auf Beitrag Nr.: 37.241.002 von falconara am 24.05.09 14:57:21

...man kann ja mal fragen
Mein Depotanteil an dieser Aktie beträgt momentan nominell weniger als 50 Euro

[Helenium]

guten morgen,

nach auskunft meiner bank wird die aktie von xechem nur in usa in roswell gehandelt

[physik]

Antwort auf Beitrag Nr.: 37.242.928 von Helenium am 25.05.09 08:30:27

Roswell,
gut.
Dann gibt es in der Area 51 doch keine höhere Intelligenz

[steini69]

mal sehen wo die reise heute hingeht. hab nur noch 99,7% verlust aufzuholen.

[MC_DANIEL]

Antwort auf Beitrag Nr.: 37.245.741 von steini69 am 25.05.09 15:42:13

Schade, hätte ich auch gern gewusst aber:

Feiertag in den USA (Memorial Day) - Börsen geschlossen Feiertag in den USA (Memorial Day) - Börsen geschlossen

wir müssen wohl bis morgen warten

[steini69]

Antwort auf Beitrag Nr.: 37.245.817 von MC_DANIEL am 25.05.09 15:50:56

oops, klaro, vor lauter arbeit kaum noch zeit für börse, da übersieht man so was schon mal.

na dann auf morgen.

steini

[falconara]

Antwort auf Beitrag Nr.: 37.245.919 von steini69 am 25.05.09 16:01:38

ja aber HALLOOOOO!
Steini, schön,daß DU auch "noch lebst"!
servus, "da falconara" war da!

[id4]

Antwort auf Beitrag Nr.: 37.245.741 von steini69 am 25.05.09 15:42:13

hi steini

ich weiss was passiert.
wieder runter.
mein einstandskurs 0,002

würde mich freuen , wenn ich die chance bekomm die nochmal loszuwerden.

gruss

[Helenium]

Antwort auf Beitrag Nr.: 37.245.741 von steini69 am 25.05.09 15:42:13

mit den verlusten geht es wahrscheinlich den meisten hier ganz ähnlich...
ob die jemals wieder ausgeglichen werden....?

hab irgendwo in einem nebensatz gelesen, dass xechem irdenwie mit bristol-myers (Pharmakonzern) zusammenarbeiten will, konnte aber nichts nähers in erfahrung bringen...

news wären nicht schlecht

[Helenium]

Antwort auf Beitrag Nr.: 37.243.198 von physik am 25.05.09 09:30:04

du meinst, mit ankunft der aliens ist der durchschnitt des iq noch mehr gesunken?

[physik]

Antwort auf Beitrag Nr.: 37.250.084 von Helenium am 26.05.09 09:28:31

nein, ich meine mit dem Handel von XKEM an der Bank von Roswell ist der Nachweis erbracht: es gibt kein intelligentes Leben im All.
Generell

[Helenium]

Antwort auf Beitrag Nr.: 37.252.164 von physik am 26.05.09 12:58:16

es gibt kein intelligentes Leben im All.

also wir menschen mit eingeschlossen ?

[roja]

aktuell 0,0009

[OttomanRosen]

Da ist Richtig Potenzial dahinter

[physik]

Antwort auf Beitrag Nr.: 37.253.467 von Helenium am 26.05.09 15:35:37

yep

[physik]

Antwort auf Beitrag Nr.: 37.255.595 von OttomanRosen am 26.05.09 18:23:47

naja, wenn man das Teil handeln könnte, wären diese paarhundert Prozent Schwankungen schon ganz witzig...

[roja]

wenn in der dem komma noch zwei nullen verschwinden bin ich sehr glücklich

[MC_DANIEL]

hätte nicht gedacht dass hier noch mal was zuckt

[Thund0r]

Wow, ich bin auch echt begeistert, allein von der Tatsache, dass hier überhaupt nochmal Bewegung reinkommt.

Und schwups sind auch alle stillen Mitleser wieder da - mich eingeschlossen

Finde ich aber sehr schön, dass doch alle Gebeutelten noch ein Auge auf Xechem halten.

Kann denn inzwischen jemand sagen, woher dieser Kurssprung auf einmal rührt? Irgendjemand, der im IHub ggf. mitliest und dort Informationen erhält? Wäre schön, etwas Klarheit zu erhalten.


Eine ver30-fachung noch, und ich bin bei meinem Einstandskurs


Viele Grüße an alle,
Thund0r

[Helenium]

hallo, hier was zum lesen, nicht unbedingt neu, (april 2009)



A Sickle Cell Remedy: Why are Firms Holding up Production?




- ADVERTISEMENT -










Sickle Cell Disease (SCD) is a disease that I have personally been affected by. I lost a very close friend to the disease and like many Nigerians, I know people who either suffer from the disease, or due to Nigerian law, cannot marry the one they love because either is a genetic carrier of the the disease. Given these realities, I was ecstatic to learn of a remedy to SCD that was discovered in Nigeria but upon further research, I have more questions than answers.

An Indigenous Remedy for Sickle Cell

A family in Nigeria knew of an indigenous remedy for sickle cell anemia - a disease suffered by at least 12 million people, with 70% of them residing in Africa. The family shared their recipe with Nigeria's National Institute for Pharmaceutical Research and Development (NIPRD) which in turn developed a drug called Niprisan. Niprisan was officially launched by former President Obasanjo in 1996. Amid controversy, NIPRD sold the rights to develop Niprisan to the Nigerian subsidiary of an American company – Xechem International, in 2003, with an understanding that the drug, marketed as Nicosan, would be manufactured in Nigeria.

A Corruption Scandal

Unfortunately, Xechem Nigeria became mired in corruption scandals. Its state-owned partner, Sheda Science and Technology Complex (SHESTCO), which was created by the Nigerian government to "help Xechem Nigeria produce and commercialize Nicosan", was also accused of fraud to the tune of N400 million in public funds. Xechem Nigeria's parent company filed for bankruptcy in 2008. In addition, company shareholders have leveled the following complaints,"...that the company ... failed for 12 months to retrieve from customs in Lagos US$4.3 million in new equipment purchased for Xechem's manufacturing facility in Abuja and US$2 million in equipment removed from Xechem's former facility in New Brunswick, New Jersey.[that] [t]here had been "no movement on Food and Drug Administration (FDA) approvals in 16 months; ...the termination of planned clinical trials for Xechem's sole marketable product, Nicosan; and numerous allegations against the managing director of Xechem Nigeria".

My Thoughts

It remains amazing to me that in this day and age, we are yet to fully conquer SCD. So, when I learned that there was a cure that came from Nigeria and from indigenous herbs in the form of Nicosan, I excitedly wanted to learn everything I could about it and share that information with anyone willing to listen. To then discover via research that after years over 10 years, Nicosan is still not reaching enough of the people who need it, was disappointing. To also learn that the companies charged with producing the drug - Xechem Nigeria and SHESTCO - were facing charges by the Economic and Financial Crimes Commission was even more disheartening.

Assuming that Nicosan works, it has the potential to transform the lives of millions of sufferers not only in Nigeria, but indeed around the world. Why is there a holdup in production, and information about this medicine?

For a country like Nigeria which is obviously concerned with transforming its international image, Nicosan presents an excellent opportunity to present the country as a nation of scientific achievement and one that can change the lives of millions of SCD sufferers the world over. Why this golden opportunity has not been exploited is beyond me, but it is not too late. Sadly, the fact that the drug is riddled in controversy and that no clear information is readily available about the government's plans for the drug, other than that it will now temporarily manufacture the drug, only reinforces the many negative stereotypes Nigeria faces. This is unfortunate, and I hope that in the weeks to come, Nigerians and others hoping for more news, will learn more about this drug.

Considering that President Yar'Adua is concerned with the "need to present an optimistic outlook, renew the national spirit, and reinvigorate [citizen's] faith in Nigeria," Nicosan could be the wonder drug that families are desperately looking for and that the Nigerian psyche needs.

The successful manufacture and use of this drug would instill national pride and optimism. It would elevate the level of trust and respect for the Federal Government that is currently lacking. Additionally, a thorough investigation into the missing N400 million that Xechem Nigeria and SHESTCO are accused of stealing would remind Nigerians that nobody is above the law and no person or organization will avoid justice, if necessary.

Nicosan presents an opportunity for Nigeria to do something incredible - tomass manufacture a local remedy to a disease that takes lives. Such an accomplishment would be positive and would be one of many ways to transform Nigeria's negative international image while coincidentally instilling pride in Nigerians. But even more importantly, it would save lives.

I can only hope that Nicosan will prove to be the wonder drug that sickle cell sufferers and Nigeria needs.

By Solomon Sydelle

Nigerian Curiosity

[mani40]

Antwort auf Beitrag Nr.: 37.256.885 von Thund0r am 26.05.09 20:29:09

von alleine dürfte sich der Kurs wohl nicht nach oben bewegen ...

Vielleicht tut sich ja was mit der Truppe, die das Nicosan vor dem Verramschen schützen wollte?

oder Insolvenzrücknahme?


jedenfalls noch nichts veröffentlicht, na ja die Insider sind ja wie gewohnt immer schneller ...
http://www.xechem.com/


bin mal gespannt, ob wir heute hier eine Null verlieren

aktuell 0,0009 US$

[Mahenscho]

ich wünsche euch allen viel glück das hier weiterhin bewegung drin bleibt

[MC_DANIEL]

Geht stark weiter

hab allerdings das Gefühl dass nur gezockt wird

[mani40]

Antwort auf Beitrag Nr.: 37.263.182 von MC_DANIEL am 27.05.09 15:48:39

aber wenigstens ist eine Null futsch, auf zur nächsten ...

[steini69]

Antwort auf Beitrag Nr.: 37.262.569 von Mahenscho am 27.05.09 14:52:46

Hey Großer,

ewigkeiten nix von dir gelesen. Wie gehts denn so? Wo treibst du dich denn rum so börsenmäßig?

Steini

[Helenium]

war wohl nur ein kurzer zock...?

[Thund0r]

Scheint mir fast so...wäre ja auch zu schön gewesen.

Aber die frisch aufgekeimte Hoffnung stirbt natürlich zuletzt

[roja]

oder die ruhe vor dem sturm

[Mahenscho]

hast ne bm steini..

Rot wird auch wieder Grün wenn man nicht nur Schwarz sieht!

[Helenium]

guten morgen,

ich schätze das wars dann wohl...
da haben ein paar wieder ganz schön lehr(leer)geld gezahlt...

was mich interessieren würde, ob tatsächlich anstrengungen unternommen werden um aus chapter 11 wieder rauszukommen...

finde hierztu keine infos...

alles gute weiterhin

[Helenium]

hallo miteinander...

habe hier was aus dem ihub...

Only if CEO stands for Chief Expansion Officer...

Speaking of which, we have a guy in Uganda talking to their regulatory agency about the necessary paperwork needed to get an application in. He's also got a guy working on Kenya and Tanzania and we know someone who knows that President of Gabon. We are just trying to find out what we need to get things in other areas. I figure the more positive things we do, the more people will realize that we are serious and capable of doing what the current management couldn't do over the last two years... FYI, NIPRD is fine with me talking about Nicosan with these people, since they currently have no one holding the license...

Certain people at NIPRD and the board of directors at Sheda were impressed. The BOD at Sheda were happy to have someone actually tell them what's going on. Xechem is in their complex, they are a 3% owner in the company and they have absolutely no idea what's going on. Fortunately the new DG and the Acting DG (they haven't officially announced he new DG yet, so they still have an Acting DG) are both very interested in what we are doing and want to help us in any way they can.

offensichtlich hat monty es geschafft burg und swift zu canceln und die geschäfte von xechem wieder anlaufen zu lassen bzw. er ist momentan dabei die produktion wieder anzukurbeln...
das hab ich mir jetzt aus den postings dort zusammengeschaufelt und ist somit nur meine meinung...

aber die sind im ihub total euphorisch, monty ist dort der held...

vielleicht wirds ja doch noch was...

alles gute weiterhin

[roja]

Antwort auf Beitrag Nr.: 37.321.098 von Helenium am 04.06.09 17:10:13

vielen dank für die info

[physik]

Antwort auf Beitrag Nr.: 37.321.098 von Helenium am 04.06.09 17:10:13

neinnein, Swift und Burg sind nicht gecancelt. LaMonte Forthun macht große Stimmung für das Potential von Nicosan, da ja die Lizenz eingezogen wurde, er aber - zusammen mit Pandey - diese gerne zurück hätte.
Wenn Pandey und Team die NIPRD und auch potentielle Investoren sowie Kreditoren davon überzeugen kann, daß es unter seiner Leitung massive Umsätze geben kann und er Vertriebskanäle hat, dann ließe sich das Konkursverfahren beenden.

Man sollte immer bedenken: Pandey ist ebenfalls noch BoardMember. Pandey klagt auf Zahlung außstehender Gehälter (für sich). Er wird gerne als uneigennützig dargestellt, aber er bekam (und bekommt) als Boardmember ein stattliches Gehaltm, während die Aktionäre nur Verluste schreiben.
Aber er hat einen guten Ansatz, will seine Gewinne mit einer guten Tat kombinieren.

Nebenbei haben Swift und Co NIPRD wegen des Rückzugs der Lizenz verklagt. Dies ist äußerst dumm, da die Lizenz zurückgezogen wurde als wiederholt angefragte Berichte nicht abgegeben wurden.

Also, noch steht alles ganz am Anfang.

Sollte LaMonthe Forthun mit seinen Verfahren (gegen ihn wird natürlich parallel massiv geklagt, da die Boardmembers ihn unglaubwürdig machen müssen) Erfolg haben, dann kommen die Verhandlungen mit neuen Investoren. Die können immernoch so aussehen, daß die Kreditoren deutlich zurechtgestutzt werden - also auch die Aktionäre. Es könnte z.B. sein, daß alle alten Aktien wertlos werden und neue ausgegeben werden... etc.

Ich habe ein wenig von den 'wissenschaftlichen' Ansätzen von Pandey gesehen und bin absolut nicht überzeugt, daß seine Experimente mit Nicosan Hand und Fuß haben. Es wäre sicher am schlausten, dieses Mittel als Nahrungsergänzngsmittel genehmigen zu lassen - ein Medikament ... nein, noch lange nicht.

Ein solides Investment sieht anders aus. Aber eine spannende Story ist es schon.

[Helenium]

danke für die fundiertere info...

vielleicht bleiben die jungs und mädels überm teich bei ihrer euphorie und kaufen den kurs weiter hoch...

bis dann...

[Strandlaeufer1]

!

Dieser Beitrag wurde moderiert.

[Helenium]

!

Dieser Beitrag wurde moderiert. Grund: Korrespondierendes Posting wurde entfernt

[Helenium]

nanu, wo sind den die postings von strandläufer1 und mir vom 19.06.2009 abgeblieben???

was soll denn das?

auf jeden fall es tut sich was....
abwarten

[Lapalie]

http://ih.advfn.com/p.php?pid=nmona&cb=1247252624&article=38…" target="_blank" rel="nofollow ugc noopener">http://ih.advfn.com/p.php?pid=nmona&cb=1247252624&article=38…

[Helenium]

Antwort auf Beitrag Nr.: 37.552.420 von Lapalie am 10.07.09 21:17:58

hab ich das richtig verstanden?

es gibt gar keine patente und dr. pandey hat es nicht öffentlich gemacht, nachdem er später kenntnis davon erlangte?

[falconara]

Antwort auf Beitrag Nr.: 37.555.935 von Helenium am 12.07.09 10:48:29

tja,
das würde dem entsprechen, was ich am Anfang dachte, jedoch nicht selbst befolgte:
NIGERIA-"MAFIA"

[biomatrix]

es geht vermutlich richtung norden,schaut gut aus ich werde noch welche kaufen.:

[Helenium]

Antwort auf Beitrag Nr.: 37.634.855 von biomatrix am 23.07.09 19:26:53

wie kommst du denn da drauf?

[CFalko]

Kommt denn jemals noch was von Xechem?

[Helenium]

Antwort auf Beitrag Nr.: 37.797.836 von CFalko am 17.08.09 21:18:45

hallo,
vor ein paar tagen kam von monty eine mail. er hat ausdrücklich wieder darum gebeten, diese mail nicht ins forum zu stellen. Ich denke soviel kann ich sagen, dass er zur zeit wieder in nigeria ist oder hin will, scheinbar laufen die dinge doch nicht so rund wie angedacht und es stehen offenbar schwierige verhandlungen an.

... bleibt nur abwarten...

bis bald

[CFalko]

Antwort auf Beitrag Nr.: 37.798.778 von Helenium am 18.08.09 00:31:38

Danke für die Info

[Eskobar69]

Antwort auf Beitrag Nr.: 37.798.778 von Helenium am 18.08.09 00:31:38

Glaubt hier im Ernst noch einer, dass die Firma bzw. der Aktienkurs noch mal nach oben geht?
(davon abgesehen, dass die Aktie in Deutschland eh keine Kursfestsetzung mehr hat).

Dieser (Anwalt) Monty hat sich der Sache doch auch nur angenommen, weil er als Vertreter der Geschädigten daran verdient. Auch wenn er´s nicht zugibt. Glaube aber nicht, dass er aus reinen samaritischen Gründen und auf seine Kosten da hin und her fliegt....

Vielleicht hab ich auch was falsch verstanden. Dann bitte um Aufklärung.

[Helenium]

hab ich aus einem anderen thread:

Zentralbank greift auf Vorstandsetagen durch - Regierung sichert Einlagen
Von Frank Räther, Johannesburg

Börsen-Zeitung, 8.9.2009 In Nigeria haben die Behörden die Jagd auf Banker begonnen, die ihre Finanzinstitute in Schwierigkeiten gebracht haben. Die Chefs von fünf Großbanken wurden vom Gouverneur der Zentralbank gefeuert, weil sie in verantwortungsloser Weise Milliarden faule Kredite angehäuft haben sollen. Dies betrifft die Union Bank, die Intercontinental Bank, die Oceanic Bank, die Finbank und die Afribank. Drei der Bankchefs wurden bereits von der Polizei festgenommen. Die Zentralbank musste diesen Banken mit 2,6 Mrd. Dollar zur Hilfe kommen, um sie vor dem Zusammenbruch zu retten. Etwa ein Dutzend weiterer Banken werden jetzt hinsichtlich ihrer Schulden und Liquidität untersucht.

keine ahnung was dies für xechem bedeuten könnte...

[stevie0902]

Hallo,
lange nicht mehr mit der Aktie beschäftigt.
Wird sie überhaupt noch gehandelt?

[boss1970]

Antwort auf Beitrag Nr.: 37.798.778 von Helenium am 18.08.09 00:31:38

hallo kann mir mal einer eine nachricht zukommen lassen, wie es um xechem steht. ich wäre sehr dankbar dafür.

danke

[LoloXP]

Antwort auf Beitrag Nr.: 37.980.149 von boss1970 am 15.09.09 10:33:48

Wird wohl jeden Augenblich explodieren...
10000% sind locker drin !!!

[boss1970]

Antwort auf Beitrag Nr.: 38.203.580 von LoloXP am 19.10.09 09:41:36

bist ja ein richtig schlaues kerlchen

[Lapalie]

Fotos
http://www.facebook.com/album.php?aid=2027909&id=1112943799&…

[tobitorpedo]

Antwort auf Beitrag Nr.: 38.542.432 von Lapalie am 10.12.09 11:50:13

Und jetzt?

[Lapalie]

Antwort auf Beitrag Nr.: 38.542.432 von Lapalie am 10.12.09 11:50:13

http://www.facebook.com/l/b7466;tinyurl.com/yzely5e

[Lapalie]

Antwort auf Beitrag Nr.: 38.544.783 von tobitorpedo am 10.12.09 16:19:34

Warten und warten.....

[Lapalie]

Antwort auf Beitrag Nr.: 38.620.959 von Lapalie am 22.12.09 22:02:19

Mit diesen Link findet man Monty's jüngsten Vorschlag zur Verwaltung von XeChem Nigeria ...
http://www.facebook.com/l/b7466;tinyurl.com/yzely5e

Ich wünsche Euch Allen ein schönes Weihnachtsfest
und ein gutes Neues Jahr.

Geld ist nicht Alles.
Lapalie

[stevie0902]

Hallo miteinander,

weiß eigentlich jemand ob es noch ein fünkchen Hoffnung gibt, bzw.
ob diese Aktie noch irgenwo gehandelt wird?

[Strandlaeufer1]

Antwort auf Beitrag Nr.: 38.752.563 von stevie0902 am 17.01.10 11:55:05

Ja,gehandelt wird noch, hier:
USOTC:XKEMQ

[Helenium]

Antwort auf Beitrag Nr.: 38.752.563 von stevie0902 am 17.01.10 11:55:05

hallo miteinander,

ich denke ein paar werden auch die neueste mail von monty vom 19.01.2010 bekommen haben. Er hat wieder gebeten diese nicht hier ins forum zu stellen.
...es scheint weiter zu gehen...

[falconara]

Antwort auf Beitrag Nr.: 38.762.075 von Helenium am 19.01.10 10:07:04

hab' leider nichts bekommen!
kannst Du mir BITTE etwas (INFO) zuschicken!!!???

[freshmeat]

Antwort auf Beitrag Nr.: 38.762.075 von Helenium am 19.01.10 10:07:04

@Helenium,
ich habe leider auch nix bekommen, wäre nett wenn Du mich nicht Dumm sterben liesest ....
Andererseits, würde mich dann die XMKX Story auch nicht mehr nerven :-) Dank Gruss Fresh

[falconara]

Antwort auf Beitrag Nr.: 38.762.075 von Helenium am 19.01.10 10:07:04

Helenium, DANKE, Dein mail erhalten
und
ist ok ("Lippen bleiben geschlossen)
mfG
falconara

[reitenhammer]

Antwort auf Beitrag Nr.: 38.769.360 von falconara am 19.01.10 23:46:51

hallo ich bin neu in diesem forum, habe aber schon ein paar jahre xechem auf dem buckel. kann mir jemand mal eine info geben wo ich den aktuell stand der dinge her bekomme.
danke

[falconara]

Antwort auf Beitrag Nr.: 38.782.352 von reitenhammer am 21.01.10 15:05:19

z.B hier
23.12.09 12:16:07 Beitrag Nr.: 38.623.761

solltest DIR evtl. ein wenig Zeit nehmen und selbst mal
"hier zurück-blättern"

mfG

[Helenium]

hallo miteinander,

es gibt ein update von monty vom 10.02.2010,

wie immer nur per bm und nicht zur veröffentlichung in irgend einem forum

mfg

[falconara]

Antwort auf Beitrag Nr.: 38.932.382 von Helenium am 12.02.10 10:44:26

Hallo!!!
BITTE schick' mir die NEUHEIT!!!

DANKE im VORAUS
mfG
falconara

[falconara]

Antwort auf Beitrag Nr.: 38.932.382 von Helenium am 12.02.10 10:44:26

Hallo "hel.."!

DANKE, hab' noch nicht gelesen, später, denn als alter Rentner hat "man" nicht viel Zeit!

mfG
und
nochmaligem Danke

falconara

[Schneemann1973]

Hallo Kollegen

Ich bin seit dem Hype vor ca. 5 Jahren dabei.
Was gibts denn für Neuigkeiten, wirds doch noch mal was?

Damals war ja der BigDaddy unser Freund und Hoffnungsträger.

Also klare Frage:

Geld weg oder evtl. noch ne Chance?

Grüsse

[stevie0902]

Wo kann man das Wertlose Papier eigentlich noch verkaufen?
Irgendwie glaube ich nicht mehr dran, dass das Teil noch nicht mal 1 cent erreichen wird

[Schneemann1973]

Antwort auf Beitrag Nr.: 38.997.550 von stevie0902 am 23.02.10 21:00:34

Hallo

Also ich weiß nicht so recht, verrotten lassen oder verkaufen ist bei dem Kurs eh das gleiche.
Liegen ja gut rum die Teile.
Nur schade ist, dass die Infos nicht mehr so gut laufen, weil ja keine Sau mehr schreibt...


Grüsse vom Schneemann

[LoloXP]

[Helenium]

Hallo,

ist da draussen noch jemand?

es gibt wieder news von monthy,

wie bisher auch dürfen diese nicht hier oder sonstwo reingestellt werden,

wer es lesen möchte bitte kurze bm


alles gute weiterhin

[falconara]

Antwort auf Beitrag Nr.: 39.726.442 von Helenium am 23.06.10 15:42:58

bitte lesen lassen

falconara

[Mosessohn]

Antwort auf Beitrag Nr.: 39.726.442 von Helenium am 23.06.10 15:42:58

Hallo
Kann ich die news auch haben
Danke im voraus
Moses

[Helenium]

hallo leute,

Xechem Update 7-14-10

wer es lesen will, wie immer bitte per bm

alles gute

[falconara]

Antwort auf Beitrag Nr.: 39.828.779 von Helenium am 15.07.10 21:35:17

ok und Danke im Voraus

[falconara]

Antwort auf Beitrag Nr.: 39.828.779 von Helenium am 15.07.10 21:35:17

vielen Dank!

Ich meinte, ob die Aktie jemals noch etwas positives wird, also keine Negativ-Frage!!

ok???

mfG

[Helenium]

Antwort auf Beitrag Nr.: 39.836.857 von falconara am 17.07.10 16:28:02

bitte schön,

ob die Aktie jemals noch was positives wird?

ich denke wir können alle nur hoffen, manchmal passieren noch wunder....

alles gute

[montamero]

Artikel von Monty im Brunswick Sentinel:

http://nbs.gmnews.com/news/2010-07-21/Front_Page/Local_man_s…

Local man seeks to produce drug for sickle cell disease
LaMonte Forthun is assisting Xechem Nigeria
BY JENNIFER BOOTON
Staff Writer
ASouth Brunswick man is hoping to team up with Nigerian officials to produce an organic drug that some say effectively treats sickle cell disease (SCD).


Mothers and children in Nigeria learn about Nicosan, a drug that can be used to treat sickle cell disease, at an outdoor marketing booth. South Brunswick resident LaMonte Forthun has been involved with trying to get Xechem Nigeria, the company that produces the drug, up and running again.
PHOTOS COURTESY OF LaMONTE FORTHUN
LaMonte Forthun, of Monmouth Junction, submitted a proposal last year to the lenders of Xechem Pharmaceuticals Nigeria Ltd., a global pharmaceutical company, to take managerial control of the organization.

Before it was driven into bankruptcy in 2009, the company had been producing an all-natural drug called Nicosan, which many users credit with alleviating SCD symptoms and reducing the number of sickle cell crises.

SCD is a blood disorder that affects red blood cells. When sickleshaped cells block small blood vessels, blood flow is impeded and tissue becomes damaged, causing an exorbitant amount of pain.


The finished product for Nicosan sits on the shelves at a warehouse in Nigeria.
Statistics show that approximately 4 million people in Nigeria live with SCD, according to Forthun, though he believes the actual number is much grimmer, estimating it could be as high as 10 million. He also said there are millions more who have the sickle cell trait, which means they don’t have the disease but have the ability to pass it on to their children.

SCD is less common in the U.S., affecting an estimated 70,000 to 100,000 Americans, according to the Centers for Disease Control and Prevention.

There is currently no universal cure for the disease, though there is a U.S. Federal Drug Administration (FDA)-approved drug called hydroxyurea, which is used to treat cancer but also alleviates SCD symptoms. Forthun claims that Nicosan would be void of the side effects caused by cancer drugs,.


The raw materials for Nicosan, an all-natural drug that can be used to treat sickle cell disease, wait for production of the drug to resume.
PHOTO COURTESY OF LaMONTE FORTHUN
Nicosan is made of four different plants and was first developed by a natural healer in Nigeria. Nigeria’s National Institute of Pharmaceutical Research and Development (NIPRD), which is a division of that country’s Ministry of Health, took hold of the raw material in 1990 and developed the drug into what it is today.

The drug received approval from Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC), which Forthun said is that country’s counterpart to the U.S. Food and Drug Administration. In 2006 the drug was awarded approval by the Nigerian agency for marketing, and it hit Nigerian shelves in 2007.


Pictured is the front entrance of Xechem Nigeria, where Nicosan, an all-natural drug that has been used for sickle cell disease, was being produced. South Brunswick resident LaMonte Forthun has been involved with trying to get the company up and running again.
PHOTO COURTESY OF LaMONTE FORTHUN
Though it has yet to be approved for sale in the U.S., in August 2003 the USFDA designated Nicosan as an orphan drug, a designation given to drugs used to treat rare diseases, or diseases that occur in fewer than 200,000 Americans.



“It was given orphan drug status, meaning the FDA determined that it’s worth putting some effort into it,” he said.

It also holds that status in the European Union.

The orphan drug designation provides Nicosan with a waiver of regulatory filing fees, access to research grant opportunities, fast-track FDA review, and seven years of market exclusivity if it is approved by the FDA. But drugs holding that designation must still prove they are safe and effective through research and clinical trials before the FDA will give them approval for marketing.

“Just because they have orphan drug status doesn’t mean they can be marketed,” Forthun said. “What it means is that when the proper applications are submitted, the product is taken through the system a bit faster.”

Most Nicosan users live in Nigeria, Forthun said, estimating there were 5,000- plus in the sub-Sahara country before it was taken off the market. In the United States only “a handful,” fewer than 50, were using the drug, since the only way to obtain it was by mail or travel to Nigeria, he said.

Despite the large discrepancy between the number of Nicosan users and the number of SCD sufferers, the drug has a solid reputation in Nigeria and is known globally among the sickle cell community, according to Forthun.

Tosin Ola, 29, from Portland, Ore., said she’s been taking Nicosan since 2007.

“In that time I’ve only had one crisis, and it was because I ran out of Nicosan,” she said, noting that before taking the drug she would have a crisis every three months.

Ola obtained Nicosan through an American man who frequently traveled to Nigeria. He would buy and ship several boxes of the drug to her, she said.

The problem, Forthun said, is that production has been halted for the past year, and those who depended on the drug are forced to go without it.

“You need to take it every day, and it takes one or two months for the product to get into your system and start reducing crises and start making you feel better,” he said.

Ola said it’s been nerve-wracking trying to obtain the drug since it went out of production, and she believes she recently had her first crisis in three years due to the product’s lag.

“Many of the people that I recommended Nicosan to have suffered greatly [since production stopped] and have been thrown back into the cauldron of crises and pain,” she said.

NIPRD scientists, who have been working with the product for two decades, have seen firsthand the ramifications in Nigeria caused by the drug’s unavailability, according to Forthun.

“They’ve had parents coming to their office begging for the product and breaking down,” he said. “We have a chance to help 50 million people worldwide.”

Nicosan was in production for a few years before Forthun became involved in 2008. The company was in a downward spiral at the time, and Forthun came on board to make use of his marketing and sales expertise. After four trips to Nigeria and conversations with government officials and scientists, his passion for the product grew and the company’s success became a priority.

Forthun, who lost his best friend to cancer at the age of 19, said he’s always had a desire to give back and do something beneficial with his undergraduate chemistry degree.

“All of a sudden I got thinking: This is an opportunity to get back into what I always felt I was meant to do,” he said, noting that after college he pursued a career in sales. “This project is about doing something big. The number of people we could help with this small production facility is incredible, and the types of products and projects we could have access to are nothing short of a miracle to those that need the help.”

After Xechem Nigeria went bankrupt, its lenders, NEXIM Bank, Diamond Bank and Bank PHB, who are owed millions, invited proposals to reinvigorate the company.

Forthun’s proposal lays out a plan for global expansion, an increased portfolio of products, and an effective marketing strategy to get the company back on track. He also hopes to bring the product to the U.S. and eventually open an American office.

If he does receive ownership of the company, Forthun has the option of pursuing FDA approval in the U.S., which, he said, could be difficult and time-consuming, or he could seek approval for Nicosan as a nutraceutical, which, he said, is an easier process and could get the product to market more quickly.

“It’s far more difficult to standardize a product made from plants than it is a synthetic product, [and] this is a bankrupt company that can’t wait two years to attempt to get FDA approvals before putting something on the market,” Forthun said. “That doesn’t mean it won’t happen or that we won’t go through the process, but since it’s a product that can be brought into the country as a nutraceutical, it might be the best thing for the company and for those that need it.”

As a nutraceutical, the company would work with sickle cell foundations to market the product directly to those who need it most.

“One-to-one marketing and word of mouth: the product works and those that use it successfully will tell others they know,” he said. “I’ve found that Facebook is an incredible networking tool and have contacts with thousands of sickle cell sufferers, advocates, associations and researchers. I just need the product now.”

It has been determined, however, that to get the “proper respect” from Western doctors, it would need to have FDA approval, he said.

Another goal is to have the company’s label, along with Nigeria, become known as the “traditional medicine capital of the world,” which could be possible with the investigation and development of new treatments for common diseases such as HIV, tuberculosis and cancer, he said.

Forthun plans to work in partnership with NIPRD, where they would conduct research and development, while Xechem Nigeria would commercialize and sell the products.

The proposal also describes TEaM Sickle Cell, which, organized by the firm, would be a collaborative effort among sickle cell advocates, foundations, associations, health care professionals, parents and patients in testing, educating and working toward new medications. Currently the group has commitments from several foundations in Nigeria and other African countries as well as in the U.S. and others scattered around the world.

Though he believes his proposal is well liked by those charged with making the final decision, the winning proposal has yet to be determined, and production remains halted.

Forthun said it has been a frustrating 12 months but noted he will soon take another trip to Nigeria, where he has plans to meet with the Nigerian presidency, the Ministry of Health, the Ministry of Science and Technology, NAFDAC, the Pharmacists Council, NIPRD, the three banks, and Shescto, which is the biotech park that houses Xechem. He’s hopeful a decision will be made on the trip, which will be his fifth visit to the country since his initial involvement.

If everything goes as planned, he will get the company rolling in Nigeria. He will be able to lease a generic production facility in Abuja, Nigeria, and said he believes that most former production employees would be willing to return. With their years of experience plus his close relationship with the lenders and NIPRD, he thinks he’d be able to manage from afar.

“With Xechem Nigeria, there’s a manufacturing facility and there are trained and dedicated workers who have helped me tremendously during the last year,” he said. “We all have similar dreams on how we can do this, and I think we’re all in tune.”

The adult version of Nicosan, administered in pill form, was roughly $35 a month before the company went bankrupt last year, according to Forthun. The children’s dosage ran about $30.

“Those that can’t afford the drug [in Nigeria] would be subsidized by governmental programs, and I’ve had discussions with various people in the Nigerian presidency and the Ministry of Health to put a program together,” he said.

If the company, government and foundations can all work together, using TEaM Sickle Cell on a global spectrum, the drug has the potential to do a lot of good for a lot of people, he said.

“This has become less about money and more about helping millions of people, most of which are children, fight a disease that is incredibly painful and kills people,” Forthun said. “The amount of things we would be able to do would be amazing.”

Contact Jennifer Booton at

[e-mail].

[montamero]

Antwort auf Beitrag Nr.: 39.839.562 von Helenium am 19.07.10 08:49:49

Artikel von Monty im Brunswick Sentinel:

http://nbs.gmnews.com/news/2010-07-21/Front_Page/Local_man_s…

Local man seeks to produce drug for sickle cell disease
LaMonte Forthun is assisting Xechem Nigeria
BY JENNIFER BOOTON
Staff Writer
ASouth Brunswick man is hoping to team up with Nigerian officials to produce an organic drug that some say effectively treats sickle cell disease (SCD).


Mothers and children in Nigeria learn about Nicosan, a drug that can be used to treat sickle cell disease, at an outdoor marketing booth. South Brunswick resident LaMonte Forthun has been involved with trying to get Xechem Nigeria, the company that produces the drug, up and running again.
PHOTOS COURTESY OF LaMONTE FORTHUN
LaMonte Forthun, of Monmouth Junction, submitted a proposal last year to the lenders of Xechem Pharmaceuticals Nigeria Ltd., a global pharmaceutical company, to take managerial control of the organization.

Before it was driven into bankruptcy in 2009, the company had been producing an all-natural drug called Nicosan, which many users credit with alleviating SCD symptoms and reducing the number of sickle cell crises.

SCD is a blood disorder that affects red blood cells. When sickleshaped cells block small blood vessels, blood flow is impeded and tissue becomes damaged, causing an exorbitant amount of pain.


The finished product for Nicosan sits on the shelves at a warehouse in Nigeria.
Statistics show that approximately 4 million people in Nigeria live with SCD, according to Forthun, though he believes the actual number is much grimmer, estimating it could be as high as 10 million. He also said there are millions more who have the sickle cell trait, which means they don’t have the disease but have the ability to pass it on to their children.

SCD is less common in the U.S., affecting an estimated 70,000 to 100,000 Americans, according to the Centers for Disease Control and Prevention.

There is currently no universal cure for the disease, though there is a U.S. Federal Drug Administration (FDA)-approved drug called hydroxyurea, which is used to treat cancer but also alleviates SCD symptoms. Forthun claims that Nicosan would be void of the side effects caused by cancer drugs,.


The raw materials for Nicosan, an all-natural drug that can be used to treat sickle cell disease, wait for production of the drug to resume.
PHOTO COURTESY OF LaMONTE FORTHUN
Nicosan is made of four different plants and was first developed by a natural healer in Nigeria. Nigeria’s National Institute of Pharmaceutical Research and Development (NIPRD), which is a division of that country’s Ministry of Health, took hold of the raw material in 1990 and developed the drug into what it is today.

The drug received approval from Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC), which Forthun said is that country’s counterpart to the U.S. Food and Drug Administration. In 2006 the drug was awarded approval by the Nigerian agency for marketing, and it hit Nigerian shelves in 2007.


Pictured is the front entrance of Xechem Nigeria, where Nicosan, an all-natural drug that has been used for sickle cell disease, was being produced. South Brunswick resident LaMonte Forthun has been involved with trying to get the company up and running again.
PHOTO COURTESY OF LaMONTE FORTHUN
Though it has yet to be approved for sale in the U.S., in August 2003 the USFDA designated Nicosan as an orphan drug, a designation given to drugs used to treat rare diseases, or diseases that occur in fewer than 200,000 Americans.



“It was given orphan drug status, meaning the FDA determined that it’s worth putting some effort into it,” he said.

It also holds that status in the European Union.

The orphan drug designation provides Nicosan with a waiver of regulatory filing fees, access to research grant opportunities, fast-track FDA review, and seven years of market exclusivity if it is approved by the FDA. But drugs holding that designation must still prove they are safe and effective through research and clinical trials before the FDA will give them approval for marketing.

“Just because they have orphan drug status doesn’t mean they can be marketed,” Forthun said. “What it means is that when the proper applications are submitted, the product is taken through the system a bit faster.”

Most Nicosan users live in Nigeria, Forthun said, estimating there were 5,000- plus in the sub-Sahara country before it was taken off the market. In the United States only “a handful,” fewer than 50, were using the drug, since the only way to obtain it was by mail or travel to Nigeria, he said.

Despite the large discrepancy between the number of Nicosan users and the number of SCD sufferers, the drug has a solid reputation in Nigeria and is known globally among the sickle cell community, according to Forthun.

Tosin Ola, 29, from Portland, Ore., said she’s been taking Nicosan since 2007.

“In that time I’ve only had one crisis, and it was because I ran out of Nicosan,” she said, noting that before taking the drug she would have a crisis every three months.

Ola obtained Nicosan through an American man who frequently traveled to Nigeria. He would buy and ship several boxes of the drug to her, she said.

The problem, Forthun said, is that production has been halted for the past year, and those who depended on the drug are forced to go without it.

“You need to take it every day, and it takes one or two months for the product to get into your system and start reducing crises and start making you feel better,” he said.

Ola said it’s been nerve-wracking trying to obtain the drug since it went out of production, and she believes she recently had her first crisis in three years due to the product’s lag.

“Many of the people that I recommended Nicosan to have suffered greatly [since production stopped] and have been thrown back into the cauldron of crises and pain,” she said.

NIPRD scientists, who have been working with the product for two decades, have seen firsthand the ramifications in Nigeria caused by the drug’s unavailability, according to Forthun.

“They’ve had parents coming to their office begging for the product and breaking down,” he said. “We have a chance to help 50 million people worldwide.”

Nicosan was in production for a few years before Forthun became involved in 2008. The company was in a downward spiral at the time, and Forthun came on board to make use of his marketing and sales expertise. After four trips to Nigeria and conversations with government officials and scientists, his passion for the product grew and the company’s success became a priority.

Forthun, who lost his best friend to cancer at the age of 19, said he’s always had a desire to give back and do something beneficial with his undergraduate chemistry degree.

“All of a sudden I got thinking: This is an opportunity to get back into what I always felt I was meant to do,” he said, noting that after college he pursued a career in sales. “This project is about doing something big. The number of people we could help with this small production facility is incredible, and the types of products and projects we could have access to are nothing short of a miracle to those that need the help.”

After Xechem Nigeria went bankrupt, its lenders, NEXIM Bank, Diamond Bank and Bank PHB, who are owed millions, invited proposals to reinvigorate the company.

Forthun’s proposal lays out a plan for global expansion, an increased portfolio of products, and an effective marketing strategy to get the company back on track. He also hopes to bring the product to the U.S. and eventually open an American office.

If he does receive ownership of the company, Forthun has the option of pursuing FDA approval in the U.S., which, he said, could be difficult and time-consuming, or he could seek approval for Nicosan as a nutraceutical, which, he said, is an easier process and could get the product to market more quickly.

“It’s far more difficult to standardize a product made from plants than it is a synthetic product, [and] this is a bankrupt company that can’t wait two years to attempt to get FDA approvals before putting something on the market,” Forthun said. “That doesn’t mean it won’t happen or that we won’t go through the process, but since it’s a product that can be brought into the country as a nutraceutical, it might be the best thing for the company and for those that need it.”

As a nutraceutical, the company would work with sickle cell foundations to market the product directly to those who need it most.

“One-to-one marketing and word of mouth: the product works and those that use it successfully will tell others they know,” he said. “I’ve found that Facebook is an incredible networking tool and have contacts with thousands of sickle cell sufferers, advocates, associations and researchers. I just need the product now.”

It has been determined, however, that to get the “proper respect” from Western doctors, it would need to have FDA approval, he said.

Another goal is to have the company’s label, along with Nigeria, become known as the “traditional medicine capital of the world,” which could be possible with the investigation and development of new treatments for common diseases such as HIV, tuberculosis and cancer, he said.

Forthun plans to work in partnership with NIPRD, where they would conduct research and development, while Xechem Nigeria would commercialize and sell the products.

The proposal also describes TEaM Sickle Cell, which, organized by the firm, would be a collaborative effort among sickle cell advocates, foundations, associations, health care professionals, parents and patients in testing, educating and working toward new medications. Currently the group has commitments from several foundations in Nigeria and other African countries as well as in the U.S. and others scattered around the world.

Though he believes his proposal is well liked by those charged with making the final decision, the winning proposal has yet to be determined, and production remains halted.

Forthun said it has been a frustrating 12 months but noted he will soon take another trip to Nigeria, where he has plans to meet with the Nigerian presidency, the Ministry of Health, the Ministry of Science and Technology, NAFDAC, the Pharmacists Council, NIPRD, the three banks, and Shescto, which is the biotech park that houses Xechem. He’s hopeful a decision will be made on the trip, which will be his fifth visit to the country since his initial involvement.

If everything goes as planned, he will get the company rolling in Nigeria. He will be able to lease a generic production facility in Abuja, Nigeria, and said he believes that most former production employees would be willing to return. With their years of experience plus his close relationship with the lenders and NIPRD, he thinks he’d be able to manage from afar.

“With Xechem Nigeria, there’s a manufacturing facility and there are trained and dedicated workers who have helped me tremendously during the last year,” he said. “We all have similar dreams on how we can do this, and I think we’re all in tune.”

The adult version of Nicosan, administered in pill form, was roughly $35 a month before the company went bankrupt last year, according to Forthun. The children’s dosage ran about $30.

“Those that can’t afford the drug [in Nigeria] would be subsidized by governmental programs, and I’ve had discussions with various people in the Nigerian presidency and the Ministry of Health to put a program together,” he said.

If the company, government and foundations can all work together, using TEaM Sickle Cell on a global spectrum, the drug has the potential to do a lot of good for a lot of people, he said.

“This has become less about money and more about helping millions of people, most of which are children, fight a disease that is incredibly painful and kills people,” Forthun said. “The amount of things we would be able to do would be amazing.”

Contact Jennifer Booton at

[e-mail].

[falconara]

Antwort auf Beitrag Nr.: 39.839.562 von Helenium am 19.07.10 08:49:49

kennst Du sicher, oder?
http://www.facebook.com/lamontef

mfG
falconara

[LoloXP]

cu

[montamero]

Antwort auf Beitrag Nr.: 39.839.562 von Helenium am 19.07.10 08:49:49

Hallo Helenium

Lt. monty sind die aktuellen Verhandlungen bezüglich Swift etc. ausgesetzt.
Es wird eine außergerichtliche Einigung von einer Partei angestrebt.

montamero

[Helenium]

guten morgen miteinander,

neues update von monthy ist da.

wie immer nur per bm und bitte nirgends wo reinstellen.

alle gute

[falconara]

Antwort auf Beitrag Nr.: 40.426.354 von Helenium am 01.11.10 10:24:50

hallo Helenium,
danke für die Info!

Bitte wieder an mich senden.

heute wieder mal -50%.

Was glaubst Du, wie's weiter geht?

Servus

[falconara]

Antwort auf Beitrag Nr.: 40.426.354 von Helenium am 01.11.10 10:24:50

Herzlichen Dank!°
Hab's gelesen.

wird schon werden, oder so.....

[montamero]

Antwort auf Beitrag Nr.: 40.426.354 von Helenium am 01.11.10 10:24:50

Hallo Helenium
Sende mir bitte auch das update.
Danke dir!
monatmero

[Dragon68]

hallo @ all,

habe noch 155000 stck xechem im depot !
wie ist die lage, es ist schwer infos zu bekommen

wurde die produktionsstätte in negeria eigentlich fertiggestellt
und wie get es weiter ?

über einschätzungen von euch wäre ich sehr dankbar

gruß

[Helenium]

hallo an alle die da noch tapfer ausharren...


... es gibt wieder ein neues update von monthy...

wer es haben will wie immer nur per bm und bitte nirgend wo reinstellen...

alles gute weiterhin

[falconara]

Antwort auf Beitrag Nr.: 40.530.821 von Helenium am 16.11.10 15:41:35

....hallo Hele..., alles klar!
ich bitte recht herzlich darum!

servus, bis zum Tag X und dem großen Geldregen
...(die Frage ist nur: für wen?)...
mfg
falconara

[Helenium]

weist ja
...denn erstens kommt es anders...
und zweitens als man denkt...

und ein blindes huhn trinkt auch mal'nen korn

[scarlet-steffi]

Antwort auf Beitrag Nr.: 40.530.821 von Helenium am 16.11.10 15:41:35

hallo was ist eine bm

[Helenium]

Antwort auf Beitrag Nr.: 40.540.700 von scarlet-steffi am 17.11.10 19:10:03

hast bm...

[montamero]

Antwort auf Beitrag Nr.: 40.530.821 von Helenium am 16.11.10 15:41:35

Hallo Helenium

An mich auch bitte.

mfg
montamero

[montamero]

Funding woes afflict African herbal therapy institute

Promising therapies in limbo after donor money runs out.

Deborah-Fay Ndhlovu

Promising research by Nigeria's National Institute for Pharmaceutical Research and Development is being Charles Balogun/Jegede Adeola/ NIPRD
held up by the lack of funds.Charles Balogun/Jegede Adeola/ NIPRD

Research has ground to a halt at a Nigerian institute that develops traditional herbal remedies into drug candidates, after it failed to secure the funding it expected this year. Scientists are now urging the Nigerian government to provide the financial support needed to save their research programmes.

The National Institute for Pharmaceutical Research and Development (NIPRD), based in Abuja, has already developed a potential therapy for sickle-cell disease and has encouraging results for compounds to treat malaria and tuberculosis.

But a key grant from the US National Institute of Allergy and Infectious Diseases (NIAID) has run out and Nigeria's Ministry of Health has failed to deliver an expected increase to its contribution. As a result, research on all three drugs has largely come to a standstill.

The 49 million naira (US$325,000) the NIPRD received this year from the health ministry is not enough to cover the institute's annual running costs of 265 million naira, says Karniyus Gamaniel, director general of the NIPRD.

The institute also received 70 million naira from the ministry in 2010 for capital projects, but this falls short of the more than US$2 million needed to buy equipment and for other infrastructure projects.

"There are lots of things we don't do because we have no money," Gamaniel told Nature. For instance, the institute needs 50 million naira in addition to its running costs to mount an 800-patient phase III clinical trial on its anti-malaria drug.

In addition, one of the institute's flagship laboratories, set up in 2005 with a grant of US$25 million from NIAID, is lying idle. NIPRD needs about US$180,000 a year to cover maintenance costs and ensure a constant supply of electricity, Gamaniel says.

Joseph Okogun, a consultant phytochemist for NIPRD, says that without funding for this lab they cannot carry out essential analyses of the structures of chemical compounds in their tuberculosis drug candidate, which is a mix of herbal extracts that have been shown to slow the growth of the tuberculosis bacterium.

"If funded, maybe in six to ten years time we might get something developed into a drug," says Okogun.
Troubled history

Scientists contacted by Nature have been particularly dismayed by the effects of the funding problems on efforts to test Nicosan (niprisan), the institute's potential treatment for sickle-cell anaemia — a genetic disease affecting about 4 million people in Nigeria's population of 150 million.

Patients with the disease have 'sickle'-shaped red blood cells that can clump together to block blood vessels, causing strokes or pain. Based on West African plant extracts, Nicosan appeared to slow the clumping of blood cells in lab tests1 and early trials of the drug in patients suggested that it relieved some of the painful symptoms of the disease2.

Nicosan was being produced in the country by the Nigerian subsidiary of US chemical company Xechem International. But last year, the company closed its factory and despite promises by the Nigerian government that it would restart production, the drug is currently unavailable.

Although the results of phase III clinical trials with Nicosan, funded by NIPRD, have not been published, Gamaniel admits they were "inconclusive". But financial constraints have hindered NIPRD from doing more phase III trials of the drug, he says.

Marie Stuart, a professor of paediatrics and haematology at Thomas Jefferson University in Philadelphia, Pennsylvania, says that since the sickle-cell drug hydroxyurea was marketed nearly two decades ago, the list of drugs able to treat the symptoms of the disease has been "abysmally short to nonexistent".

"Nicosan is an oral agent with what appears to be minimal toxicity," Stuart says. Getting good phase III trial data is the "crucial next step", she adds.

Gamaniel says they are negotiating for additional funding from the Nigerian health ministry.

But Umar Bindir, the director general of Nigeria's National Office for Technology Acquisition and Promotion, believes that their chances of success are slim.

Ministries cannot fund any institute in excess of a yearly cap, fixed by the ministry of finance, he explains.

"It doesn't matter what you have as an institution and how important you are, the ceiling doesn't change and it's not good for R&D," says Bindir, who urges NIPRD to look for other sources of funding. "NIPRD has to intensify its own efforts by doing contract research for industry and submitting proposals to institutions such as the African Union and the European Union."

Gamaniel says they plan to do exactly that — the institute is drafting a proposal for funding which will be submitted to the World Bank and the Global Fund to Fight AIDS, Tuberculosis and Malaria. "I am very optimistic," Gamaniel says, adding that much of the funding will be used to upgrade the institute's laboratories so that they can push forward work on their drug candidates. "I believe that it is a matter of communicating the facts of this intention to the bank."

http://www.nature.com/news/2010/101118/full/news.2010.602.ht…

[falconara]

Antwort auf Beitrag Nr.: 40.545.533 von montamero am 18.11.10 13:10:39

..ob da die "Linke" ahnt, was die "Rechte" tut oder nicht
tut.....????

nigeria-conection

[montamero]

Die letze News über Niprid könnte hoffentlich den xkem-Stein ins Rollen bringen....
Das Kommentar von dazu von Monty:
That could be the best timed news article ever written...

[Helenium]

Antwort auf Beitrag Nr.: 40.550.941 von montamero am 19.11.10 00:33:54

ja, 2 Nullen weniger hinterm Komma wäre schon nicht schlecht...

es braucht wohl noch etwas geduld...

[montamero]

Production of Nicosan to begin in weeks-NIPRD DG

Stories by Emeka Umejei, Reporter, Lagos

The Director-General (DG) of Nigeria Institute of Pharmaceutical Research and Development (NIPRD), Professor Karniyus Gamaniel, disclosed that production of Nicosan, an effective drug for treatment and management of sickle-cell anemia will soon be resuscitated.

“The minister has set up a committee on the resuscitation of the Nicosan and I am sure in the next few months or weeks, Nicosan would be back may be not in large scale because what Government has done is to ask NIPRD to produce on social production. As a social responsibility to people that need Nicosan,” Gamaniel stated.

“The process takes long, NAFDAC has to inspect the facility, the council has to approve the person that is going to be in charge whose license is going to be used to re-establish it and then we start producing. We would produce for a while and in the mean time work out for a competent pharmaceutical company who will be licensed for production.”

Gamaniel, who spoke to Daily Independent in his Abuja office said Nicosan as proven effective in the management of sickle cell anemia crises and treatment.

“Nicosan does not cure but manages sickle; from our study the number of crises that victims undergo reduces significantly and the number of hospital visits. I have seen people who had bad situation but when they started using the drug their situation changed. If Food and drug administration (FDA,USA) can admit the product as orphan drug, then Nigeria should be proud that we made this kind of discovery,” Gamaniel stated.

Stating further, Gamaniel said Nicosan stopped being produced following what he described as management problem with the company that got the production license.

“Since 2008 it has not been in production because there was a management problem with the company that got the license from NIPRD to produce Nicosan, they dragged themselves to court and all that.So, NIPRD under the directive of the minister of health withdrew their license which was even challenged in a court in the United States of America(USA),” Gamaniel disclosed .

“NIPRD has never taken anybody to court but for withdrawing her license based on lay down agreements, the shareholders took NIPRD to court in the US. So, we had to pay money to sponsor lawyers to go to the US and engage a resident lawyer to defend us .We won the case but we lost money. It was an unfortunate situation because if we had that money today and we dedicate it to Research and Development of our herbal, taking into consideration the processes that we have set up we would move forward. “

http://www.independentngonline.com/DailyIndependent/Article.…

[montamero]

Antwort auf Beitrag Nr.: 40.679.587 von montamero am 09.12.10 12:26:57

Article Comment by LaMonte Forthun

On Wed Dec, 08 2010 06:28
With all due respect to Prof. Gamaniel, I'd like to make two points relating to comments made in the last paragraph of this article. 1). It was the management of Xechem International, not the shareholders, which took NIPRD to court over the revocation of the license; and 2). It was the attorney of the US shareholder's (of Xechem International) that was hired by NIPRD and whom eventually got the lawsuit dismissed. The shareholders have supported efforts to take over Xechem Nigeria to re-establish the production for over 17 months now (since the creditors of Xechem Nigeria, took Xechem Nigeria into Receivership) and have and will continue to be fully supportive of NICOSAN, Prof. Gamaniel and the entire staff at NIPRD. In Aug. of 2009 a proposal sponsored by the US shareholders was submitted to the creditors of Xechem Nigeria (at their request) outlining a new management team, financial capabilities and an operational plan. It was one of four such proposals that were requested by the cre

http://www.independentngonline.com/DailyIndependent/Article.…

[montamero]

Antwort auf Beitrag Nr.: 40.683.675 von montamero am 09.12.10 19:14:57

...und so gehts weiter:

The comment got cut off and should be updated later today, here's what I just posted as continuation of the original comment:

"It was one of four such proposals that were requested by the creditors on July 29th of 2009 and as of today, Dec. 8, 2010, no decision has been made as to how to progress. The shareholder’s plan has the support of the Xechem Nigeria employees and numerous important stakeholders. The shareholder's group is the only group that has been working tirelessly for nearly three years to resolve these problems and will continue to do so, we are all thrilled at the news that NIPRISAN will be in production again soon..."

[montamero]

...am Dienstag geht es Swift wieder an den Kragen. Es wird weiter geklagt...

[scarlet-steffi]

Antwort auf Beitrag Nr.: 40.734.503 von montamero am 19.12.10 13:01:56

Hallo gibt es was neues im xechem fall.

Gruß Steffi

[scarlet-steffi]

Antwort auf Beitrag Nr.: 40.552.228 von Helenium am 19.11.10 10:28:16

Hallo Helenium,


hast du neue Nachrichten, oder wo kann man diese erfahren, gerne auch per BM.

Gruß Steffi

Danke

[Helenium]

Antwort auf Beitrag Nr.: 40.777.710 von scarlet-steffi am 30.12.10 10:31:18

hi steffi und alle anderen leidensgenossen...

sobald ich was neues erfahre melde ich mich hier...

montamero ist ja auch ganz fleissig...

bleibt nur abzuwarten, in afrika laufen halt ein paar dinge ganz anders...

alles gute

bis zum nächsten jahr...

[falconara]

Antwort auf Beitrag Nr.: 40.780.056 von Helenium am 30.12.10 17:18:38

ich wünsch' DIR und uns ein GUTES NEUES JAHR!
Danke für die Infos
mfg
falconara

[montamero]

Ein Gutes Neues Jahr!
Es gibt nichts definitives aber 2011 scheint in Nigeria gut zu beginnen.

[montamero]

http://www.pharmaceuticalsinsight.com/file/95419/production-…

[montamero]

Adventrx agrees to buy sickle cell drug company
By Keith Darcé

Friday, January 7, 2011 at 8:13 a.m.

San Diego drug developer Adventrx Pharmaceuticals said Friday that it agreed to acquire another biotechnology company, whose main drug candidate treats a painful blockage of blood vessels in people with sickle cell anemia, in exchange for 47 percent of Adventrx’s stock.

The deal is worth $20.24 million based on the closing price of Adventrx shares prior to the acquisition announcement.

Adventrx officials wouldn’t name the privately-held target company or say where it is located.

Shares of Adventrx were down 41 cents, or 14 percent, to $2.52 in early trading after the announcement.

Owners of the target company will receive 19 percent of Adventrx’s stock as an upfront payment. The rest of the shares will be delivered when the Food and Drug Administration accepts a new drug application for the target company’s main experimental therapy, identified as TPC, and approves the drug for sale in the United States.

The milestone payments will be made in cash if Adventrx shareholders fail to approve the stock exchange, as required by stock market regulations.

Sickle cell anemia patients sometimes experience something called a sickle cell crisis, when the deformed red blood cells in their body begin to pile up in blood vessels. The condition can block the flow of oxygen-carrying blood, cause pain, damage eyes and kidneys, and trigger brain hemorhaging and strokes.

TPC, which has received an orphan drug designation from the FDA, is a molecule that lowers the surface tension of water in the blood, making the cells more slippery and less prone to clumping, Adventrx said.

Adventrx will spend between $15 million and $25 million over the next three years on a Phase 3 trial of TPC, the company said.

A Phase 3 trial of the experimental drug previously was initiated by the target company and another investor. However, that study was suspended when money for the test ran out, Adventrx said.

[e-mail] [phone] Twitter @keithdarce

http://www.signonsandiego.com/news/2011/jan/07/adventrx-agre…
http://www.adventrx.com/

Es wird vermutet dass es sich hierbei um Swift's Cosmid Corp. oder um AesRx mit Aes-103 (früher Xechem's 5-HMF) handelt (http://www.aesrx.com/index.html).

[falconara]

Antwort auf Beitrag Nr.: 40.905.414 von montamero am 21.01.11 19:14:06

was ist DAS denn????

[Zipp20]

Antwort auf Beitrag Nr.: 40.905.414 von montamero am 21.01.11 19:14:06

......danke Montamero fürs einstellen!!!!!

Das gibt ja richtig Hoffnung

[falconara]

Antwort auf Beitrag Nr.: 40.906.665 von Zipp20 am 22.01.11 08:09:04

Hallo zipp 20!
Bitte zeig' mir den Weg, wo Du da Hoffnung siehst
für unsere Speku-Investitionen?
mfG
falconara

[montamero]

Antwort auf Beitrag Nr.: 40.905.414 von montamero am 21.01.11 19:14:06

Zu der News bezüglich Adventrx handelt es sich nicht um einen potentiellen Käufer von xkem (privately-held target company) sondern eher um einen weiteren möglichen zukünftigen Konkurrenten. Natürlich falls xkem überlebt und Adventrx Phase 3 abgeschlossen hat.

[montamero]

Judge Jack B. Schmetterer-Court Calendar:

Tuesday, February 01, 2011


This[72] XECHEM INC 08BK30512, OFFICIAL COMMITTEE OF UNSECURED CREDITORS V. SWIFT ET AL AP
Status Hearing Adversary case 10-00065. (02 (Other (e.g. other actions that would have been brought in state court if unrelated to bankruptcy))): Complaint by Official Committee of Unsecured Creditors against Robert Swift, Cosmid Corp. LLC. Fee Amount $250.Status hearing


This[73] XECHEM INC 08BK30512, OFFICIAL COMMITTEE OF UNSECURED CREDITORS V. SWIFT ET AL AP
Status Hearing Hearing Continued . Status hearing


This[222] Orig[67] XECHEM INTERNATIONAL, INC. CH. 11
Notice of Hearing and Objection to Claim(s) 57 Filed by Robert E Richards on behalf of The Official Committee of Unsecured Creditors.


This[223] Orig[66] XECHEM INTERNATIONAL, INC. CH. 11
Notice of Hearing and Objection to Claim(s) 41 Filed by Robert E Richards on behalf of The Official Committee of Unsecured Creditors.


This[224] Orig[72] XECHEM INTERNATIONAL, INC. CH. 11
Notice of Hearing and Objection to Claim(s) 41 Filed by Douglas S Draper on behalf of XECHEM International, Inc..


This[225] Orig[68] XECHEM INTERNATIONAL, INC. CH. 11
Notice of Hearing and Objection to Claim(s) 57 Filed by Douglas S Draper on behalf of XECHEM International, Inc..


This[323] XECHEM INC CH. 11
Status Hearing Hearing Continued . Status hearing


This[324] Orig[278] XECHEM INC CH. 11
Motion : Uncontested Motion to Vacate (related documents [273] Order Scheduling) Filed by Sara E Lorber on behalf of Ramesh Pandey.


This[74] Orig[64] XECHEM INC
OFFICIAL COMMITTEE OF UNSECURED CREDITORS V. SWIFT ET AL AP
Status Hearing Notice of Motion and Emergency Motion to Withdraw as Attorney Filed by Kenneth A. Henry on behalf of Cosmid Corp. LLC, Robert Swift.


This[75] Orig[70] XECHEM INC 08BK30512, OFFICIAL COMMITTEE OF UNSECURED CREDITORS V. SWIFT ET AL AP
Motion : Motion to Set Hearing Ruling on Motion to Withdraw. Filed by Kenneth A. Henry on behalf of Kenneth A. Henry.

[Zipp20]

Antwort auf Beitrag Nr.: 40.906.834 von falconara am 22.01.11 10:14:06

....Tschuldigung, hab da glaub ich, was falsch verstanden.
Tut mir leid!

[montamero]

Die letzten Kommentare von Monty:

A few comments to your list, which is pretty accurate:

1). There is no connection between Nigeria and Xechem International at this point and hasn't been for almost two years now (July of 2009 when the Nigerian banks took over Xechem Nigeria).

2). Unless Swift has been incredibly quiet and has told everyone in Nigeria to never mentioned his name, he's not working on anything over there related to Niprisan or Xechem. Of course, I could be wrong, but after spending 26 weeks over there in the last two years, I'm fairly confident of this.

3). You're right, the banks want their money and sit on their a $es. What blows me away is that they are now talking about starting what they call "Social Production" because those with Sickle Cell need their medicine. Funny, 19 months ago they needed their medicine too, but where were you then boys? Why do they want to start production? Because you can't sell a drug manufacturing company/facility if you're not producing any drugs... What's the biggest travesty going on related to this situation in Nigeria right now? The fact that the banks have filed a lawsuit against NIPRD to prevent them from finding another company to produce Niprisan. That was filed in March of 2010, yet they started talking about "Social Production" in December of 2010. They must be really concerned if they waited nine months to start talking about it. Of course, here it is the end of January and they still aren't any where near starting production, unless all my "eyes and ears" have left me hanging...

Where's that leave us? Good question, but as they say, it ain't over 'til it's over...

-----------------------------------------------------------------------

The banks were on our side, but were influenced by the Receiver. NIPRD has been on our side from day one. The first time I met Dr. Inyang, in early 2009, it was clear to me that he was very much on our side. When Prof. Gamaniel took over, I believe that became stronger because I had spent a lot of time with him and a few others at the Institute and it became very clear that our ideas for what should be done with the product (Niprisan) were very similar. Unfortunately, because of the budget shortage, NIPRD doesn't have the funds to fight the banks lawsuit (that's just my opinion, they might not want to fight it, but I believe they just can't), so they are going to "play ball" with them. I don't think the management team is happy about it, but again, that's just my opinion...

As for my level of patience, I don't have much choice in the matter!

----------------------------------------------------------------------

The plan and production are one in the same actually... What NIPRD has to decide is if they'll allow the banks to continue to twist their arm. The bank's position is this: they are owed a tremendous amount of money (I said well over $10m, the figure I heard last week was closer to $15m, but I can't figure out how it possibly got that high) and they know that if the Niprisan license goes away they will never recover it. So, they've petitioned the Ministry of Health and have tried very hard to convince NIPRD to keep the license with Xechem Nigeria, a dead company (that's my editorial comment, not the bank's opinion). NIPRD's management doesn't want to work with Xechem as they feel the company is "toxic", but NIPRD's Board is leaning towards working with the banks because they don't want to have a lengthy legal battle (or so I gather).

So, the meeting that will be coming up will be for NIPRD to decide if they want to proceed with working with the banks or going off on their own and fighting them. They have my proposal in their hands, which basically at this point is to not work with the banks, but to form another company and start fresh, with NIPRD as a partner. I've told the banks that I'm not interested in working with them any longer (as of Jan. 1st). I can't justify putting every dollar of new investment into paying for old debt that will not even get us the equipment that is still being paid for because it's been sold by customs (only four of the 15 containers ended up at Xechem and apparently there's little that can be used in those four containers).

The production that Prof. Gamaniel is talking about is what they are calling "Social Production". They've come up with that phrase to make it sound like they are doing it to help those that need the drugs, but what they are really doing is getting the factory back into production so that when a potential investor comes around for an inspection it looks like they are actually working. If the banks actually cared about those that used to take Nicosan, they'd have put the product back into production a year and a half ago (but again, that's just my opinion, what do I know...). The plan was to do the production at NIPRD, but I think since they'll have the Xechem facility to use, they'll do it there. That is if Shestco hasn't kicked them out by now. Although, the banks seem to be throwing their weight around pretty well, I'm sure they'll file a lawsuit against them to make sure they can produce.

My problem with all this is that if the banks had listened to me last year when I told them that they needed to keep NIPRD and Shestco in the loop, none of the problems they currently have would be problems. I'm not claiming to have all the answers or be the "smart guy", but I thought it was common sense to keep the group that owned the most important piece in the puzzle (Niprisan) as well as your landlord (Shestco) up-to-date as to what you were doing. Instead, I was accused by the Receiver of being a busy-body and spreading "half-truths"... It's unfortunate, but the banks have taken no responsibility for what's happened here and are using their political position (NEXIM is part of the Ministry of Finance, no one wants to upset that Ministry) to try to recover from a long series of very bad decisions (and indecision).

It doesn't speak very well for foreign investment in Nigeria, that much I can definitely say as I've heard for many, many months that one of my biggest liabilities in my proposal is that I'm not a Nigerian...

It's OK though, I'm not done with Nigeria or Sickle Cell, as I said yesterday, I have options that I'm working though and another one surprisingly came up today.

----------------------------------------------------------------------

The meeting hasn't taken place and I'm not sure when it will. Their Board members live in various parts of Nigeria, so it's a bit of a logistics issue to get them all together and as has been reported recently, the Institute is dealing with a budget shortfall.

It's my belief that NIPRD is going to cooperate with the banks because they don't want to fight the lawsuit the banks filed to prevent NIPRD from awarding the license to another company (what the NIPRD board has to decide is if they'll work with the banks or fight them and find another company to license the product to). What that means is that the banks will stay in the "driver's seat" as far as Niprisan goes. From what I've heard recently, the bank debt has risen to well over $10m and they want to find a way to get it back as quickly as possible, meaning they are looking to the government to bail them out, or a large pharmaceutical company to step in and buy the company (I can see the first, but not the second). That's the word from one of the banks, but not all of them, so there's a huge battle that's been going on for many, many months as to how to proceed (which is why the factory has been closed for 18 months now). I've done everything I can to "sell" my plan to them and can only wait to hear what the banks or NIPRD decide. In the meantime, I'm looking at all options I can that will utilize the work that has been done over the last two years (building ties in the Sickle Cell Community) that can be of benefit to those with Sickle Cell as well as the investors (which is all I can say at this time).

[montamero]

Ein weiteres Produkt gegen SCD und das aus New Jersey...



Prolong Pharmaceuticals Leases 24,000-Square-Foot Manufacturing Facility, Adds Facilities Veteran to Executive Team

Dr. Hemant Misra Joins Prolong as VP, Manufacturing and Facilities Operations

SOUTH PLAINFIELD, N.J., Jan. 25, 2011 /PRNewswire/ -- Prolong Pharmaceuticals, which in October secured a $30 million funding commitment from a private investment group, today announced the signing of a long term lease on a manufacturing facility in South Plainfield, New Jersey and the formal addition of Dr. Hemant Misra to the Prolong Executive Management team as Vice President, Manufacturing and Facilities Operations.

The manufacturing facility has been used by Prolong since early 2010, and has already produced clinical batches of Prolong's oxygen transfer agent, SANGUINATE™, sufficient to take the company through the Phase I and II trials expected to begin this year. "Through this agreement we are able to take tens of millions of dollars and years of time off our product development cycle," said Prolong President Glenn Kazo. "We are already producing large scale biological product in a cGMP environment, and now is the right time to secure our longer term manufacturing facilities. Our fortune in teaming with Hemant and acquiring this particular facility at this time in our corporate history is quite remarkable."

A 30-year veteran of the pharmaceutical industry, Dr. Misra will head the process of bringing the new facility to full capacity. Prior to joining Prolong, Dr. Misra managed manufacturing operations, drug development and clinical studies for XTL Biopharmaceuticals as Vice President. His work has also included management roles as the Director of Clinical Drug Development and Corporate Development at Genzyme Transgenics, a subsidiary of Genzyme Corporation. Previously, Hemant held senior level positions at Activecyte, Inc., a Boston Consulting Group Company, at Chemsyn Science Labs and at Andrulis Pharmaceuticals.

Dr. Misra joins a team of industry leaders which has been assembled at Prolong. In addition to CEO and Scientific Founder Dr. Abraham Abuchowski, Prolong has named Glenn Kazo as President, brought aboard Richard Prince as Vice President, Quality, and added Andy Burger as Vice President, Information Services.

About Prolong Pharmaceuticals

Headquartered in South Plainfield, New Jersey, Prolong Pharmaceuticals, LLC is developing biopharmaceutical products targeting the treatment of anemia resulting from an oxygen deficiency. First founded in 2002 as a research company, Prolong is focused on sickle cell anemia, diabetic ischemia, and several trauma indications. The company's senior management team includes inventors of the most successful drug delivery technology in pharmaceutical history, PEGylation, now responsible for more than $30 billion in drug sales worldwide. In October 2010, Prolong secured a $30 million funding commitment from a private investor group. For more information visit: www.prolongpharmaceuticals.com

http://www.prnewswire.com/news-releases/prolong-pharmaceutic…

[montamero]

02/11/2011 335 Notice of Filing and the Declaration of Chairman of the Creditors Committee in Connection with the Hearing on US Trustee's Motion to Convert Filed by Robert E Richards on behalf of Official Committee of Unsecured Creditors of Xechem, Inc. et al. (RE: 331 Convert or Dismiss). (Richards, Robert) (Entered: 02/11/2011)

Doc 335 - PDF file
http://viewer.zoho.com/docs/zbybdr

OCR page 4

6. While the Committee believes that the adversary proceeding against Dr. Swift and his affiliate, Cosmid Corp., has considerable merit, the Committee is also aware that the defendants will likely appeal any adversary rulings against them in that adversary proceeding. The pendency of such an appeal and related uncertainty would make raising money for COS-103 very difficult

7. The sickle cell treatment drug, COS-103, which is a key issue in that adversary proceeding would take substantial further testing and work before it would be marketable and there can be no assurance that all of the further tests would be successful or that some other sickle cell treatment product would be commercially available before the testing and development of COS-I03 is completed. I understand that these further steps with respect to COS-I03 would likely cost hudreds of thousands of dollars and perhaps millions of dollars and would take several years.

8. The Committee will advise the Court whether any of the Committee members or any other interested party who the Committee is aware of is prepared to fund the past due US Trustee fees prior to the March 7, 2011 hearing.

FURTHER DECLARANT SAYETH NOT.

Date: February 10, 2011

Robert Kalman
Chairman - Unsecured Creditors Committee of Xechem, Inc. and Xechem International, Inc.
R5972 43V~l

[montamero]

02/01/2011 331 Notice of Motion and U S Trustee's Motion to Convert or Dismiss a Chapter 11 case Filed by Patrick S Layng . Hearing scheduled for 3/7/2011 at 10:30 AM at 219 South Dearborn, Courtroom 682, Chicago, Illinois 60604. (Williams, Daphne) (Entered: 02/03/2011)

Doc 331 - PDF file
http://viewer.zoho.com/docs/xadEMc


1 Main Document 1 page
2 Notice of Hearing-BK 1 page
3 Notice of Hearing-BK: Notice Recipients 2 pages

[scarlet-steffi]

Antwort auf Beitrag Nr.: 41.041.912 von montamero am 15.02.11 12:58:14

hallo

gibt es was neues von xechem.

gruss steffi

[montamero]

Antwort auf Beitrag Nr.: 41.192.115 von scarlet-steffi am 13.03.11 07:54:24

Hallo Steffi

Ja, es gibt was neues!
Mit 7.03. war es wo weit:
Case closed!
Nun, convert to Ch.7, leider.

03/07/2011 340 Order Converting Case to Chapter 7. (RE: 331 Granting Convert or Dismiss). Post Conversion Status hearing to be held on 4/19/2011 at 10:30 AM at 219 South Dearborn, Courtroom 682, Chicago, Illinois 60604. Signed on 3/7/2011 (Williams, Daphne) (Entered: 03/08/2011)

Doc 340 PDF file
http://viewer.zoho.com/docs/xcSzm

Melde dich, falls noch Fragen sind...
montamero

[scarlet-steffi]

hallo

warum wird denn hier noch gehandelt, wenn die aktien wertlos sind.

gruss

[montamero]

Naja 10 millionen Aktien bei 3,5 Milliarden sind kein Handel!
Auch Stocks in CH.7 kann man handeln so lange diese gelistet sind.
Die Order wurde unterschrieben und das Hearing gibt es am 19.04.
Schon mal was von pump and dump, shell buyer, caveat emptor etc. gehört.

[mani40]

Antwort auf Beitrag Nr.: 41.255.516 von montamero am 23.03.11 19:22:31

sagt mal, ist das aktuell oder läuft das Laufband schon 4 Jahre mit aktuellem Datum?


April 19, 2011

:: XECHEM NIGERIA LIMITED trains sales reps :: XECHEM gets $7 Million infusion from investors :: New Managing Director meets wth DG Human Rights Commission

http://www.xechemnigeria.com/

[mani40]

Antwort auf Beitrag Nr.: 41.388.457 von mani40 am 19.04.11 12:29:42

läuft wohl 4 Jahre mit aktuellem Datum

[montamero]

@Mani: ja das läuft schon 4 Jahre so...
@all: (letztes Kommentar von Monty)
Chapter 7 can't be averted at this point, unfortunately...

[montamero]

Antwort auf Beitrag Nr.: 41.407.218 von montamero am 24.04.11 13:47:48

D. h. die "Insolvenz" und die damit verbundene Liquitation des "Unternehmens" ist nicht mehr abwendbar.

[DasTier666]

http://allafrica.com/stories/201105241122.html

[montamero]

Antwort auf Beitrag Nr.: 41.557.728 von DasTier666 am 25.05.11 22:10:12

Thx for sharing du Tier!
Leider hat Niprisan und XN nichts mehr mit XI zu tun.
XN gehört NEXIM und Niprisan NIPRID.

[LoloXP]

Antwort auf Beitrag Nr.: 41.569.286 von montamero am 27.05.11 19:18:24

ooohhhhhh, sind die Pleite??, wie konnte denn das passieren???
Da konnte ja, auch vor Jahren schon, keiner mit rechnen...

aber 10000% Rebound steht kurz bevor - zuschlagen !!!!

[montamero]

Antwort auf Beitrag Nr.: 41.681.518 von LoloXP am 22.06.11 09:23:33

wie creativ und informativ

[LoloXP]

Danke, habe mir auch grosse Mühe gegeben!

[scharfy0077]

Antwort auf Beitrag Nr.: 42.006.009 von LoloXP am 26.08.11 11:20:43

hi

Xechem ist Pleite? also nur noch abwicklung?